cleveland bio labs  develop innovative drugs to treat cancer select page product portfolio our proprietary platform of tolllike immune receptor activators has applications in radiation mitigation oncology immunotherapy and vaccines view our product portfolio our most advanced product candidate is entolimod which we are developing as a radiation countermeasure and as an immunotherapy for oncology and other indications entolimod cblb biodefenseentolimod cblb oncology clinical trials we are aggressively pursuing development and commercialization of oncology drugs orphan applications and a radiation countermeasure enrollment is open for our therapeutic clinical trials for various indications with oncology drug candidates in the pipeline learn more about our phase  oncology studies with entolimod cblb recent news april   cleveland biolabs inc annual meeting listen to webcast april   cleveland biolabs announces commencement of in vivo biocomparability study april   cleveland biolabs announces european medicines agency positive opinion regarding the entolimod pediatric investigation plan april   cleveland biolabs announces webcast of annual meeting feb   cleveland biolabs reports  financial results and development progress nov   cleveland biolabs reports third quarter  financial results and development progress oct   cleveland biolabs announces a  million cost realignment with the department of defense read all news homecontact usterms of useprivacy policy  cleveland biolabs all rights reserved headquarters cleveland biolabs inc  high street buffalo ny  tel  fax  view map terms of use the site has been designed to provide general information about cleveland biolabs inc the following terms of use set forth the terms and conditions upon which you may access and use the site and the information and content made available through the site please read them carefully by accessing or using the site you signify that you have read understand accept and agree to be bound by these terms of use and intend these terms of use to be the legal equivalent of a signed written contract if you do not accept and agree to be bound by these terms of use please do not access or use the site permission to use cleveland biolabs grants you a personal revocable nonexclusive nontransferable license to access and use the site in accordance with these terms of use your right to access and use the site is expressly conditioned on your continued compliance with these terms of use reservation of right to modify or terminate terms of use cleveland biolabs reserves the right to modify these terms of use or to impose new or additional terms of use at any time “modified terms” modified terms may be incorporated into these terms of use by any reasonable means including without limitation by posting them to the site your continued use of the site following the incorporation of any such modified terms shall be deemed conclusively to indicate your acceptance of all such modified terms in addition cleveland biolabs may in its sole discretion terminate these terms of use or your right to access the site at any time for any reason including without limitation improper use of the site or failure to adhere to these terms of use or for no reason termination of these terms of use will not affect in any way cleveland biolabs’ rights to relief at law or in equity intellectual property rights all content of the site is protected under united states copyright and trademark law as well as other state national and international laws and regulations you may download store print and copy selected information on the site for your personal noncommercial use provided that i all hard copies of any such information include all copyright and other applicable notices included with such information on the site ii you do not modify alter or adapt the content of the site in any way or delete or modify any copyright or trademark notice contained on the site and iii you do not reverse engineer decompile or disassemble any aspect of the site cleveland biolabs inc incuron panecela and other cleveland biolabs logos and product names included on the site are the trademarks of cleveland biolabs all other product and service names contained on the site if any are the trademarks or service marks of their respective owners except as expressly provided herein nothing in these terms of use or on the site shall be construed as granting any license or right to use any copyright trademark or other intellectual property right of cleveland biolabs by implication estoppel or otherwise all rights not expressly granted in these terms of use are hereby reserved certain site content any health or medical information included on the site is for informational purposes only and is not and is not intended to be a medical diagnosis or a replacement for advice given by a physician or other healthcare professional and none of the information included on the site constitutes or is intended to constitute investment advice product candidates in development described on the site have not been found safe or effective by any regulatory agency and are not approved for any use other than in certain clinical trials information included on the site regarding any product approved for marketing is qualified in its entirety by reference to the full prescribing information for such product thirdparty information the site may include certain thirdparty information or content this thirdparty information or content does not represent the views opinions or beliefs of cleveland biolabs and cleveland biolabs disclaims any responsibility for any such thirdparty information or content forwardlooking statements this site contains forwardlooking statements within the meaning of the private securities litigation reform act of  forwardlooking statements reflect management’s current expectations as of the date of this press release and involve certain risks and uncertainties the company’s actual results could differ materially from those anticipated in these forwardlooking statements as a result of various factors these factors include among others the company’s history of operating losses and the potential for future losses which may lead the company to not be able to continue as a going concern the company’s need for substantial additional financing to meet its business objectives the potential for the loss of funding from the company’s rd grants and contracts and its ability to win additional funding under such grants and contracts the company’s failure to successfully and timely develop new products the risks inherent in the early stages of drug development and in conducting clinical trials the company’s inability to obtain regulatory approval in a timely manner or at all the company’s collaborative relationships and the financial risks related thereto the company’s ability to comply with its obligations under license agreements the potential for significant product liability claims and the company’s ability to comply with various safety environmental and other governmental regulations some of these factors could cause future results to materially differ from the recent results or those projected in forwardlooking statements see also the “risk factors” and “forwardlooking statements” described in the company’s periodic filings with the securities and exchange commission submissions you may use the site to contact cleveland biolabs with inquiries about information included on the site when you provide any information to cleveland biolabs you agree to provide true accurate complete and current information and not to use a false or misleading name or a name that you are not authorized to use you shall not transmit information to or through the site that i infringes or violates any intellectual property right or privacy right of any third party or ii contains confidential information or trade secrets belonging to you or any third party cleveland biolabs does not want to receive any such information any ideas suggestions information knowhow material or other content transmitted to or through the site will be deemed to include a royaltyfree perpetual irrevocable transferable worldwide nonexclusive right and license for cleveland biolabs to adopt publish reproduce disseminate transmit distribute copy use create derivative works display in whole or part or act thereon without any approval or consideration from you in any form medium or technology now known or later developed for the full term of any rights that may exist therein cleveland biolabs makes no promise express or implied that it will not use any such idea suggestion information knowhow material or other content for its own purposes which may include reproduction publication broadcast and posting links the site may provide hypertext links to other web sites that are not owned or controlled by cleveland biolabs these links are provided for your convenience only these web sites are controlled by third parties that cleveland biolabs does not control accordingly cleveland biolabs expressly disclaims any responsibility for the content of such web sites for the accuracy or reliability of the information thereon and for the quality of products or services provided thereby or advertised thereon no link included on the site constitutes an endorsement of cleveland biolabs of any content of information on or product or service provided by or advertised on any such web site if you choose to hyperlink to another web site you do so at your own risk cleveland biolabs reserves the right to terminate any hypertext link without notice security you are prohibited from violating or attempting to violate the security of the site without limiting the generality of the foregoing you may not i access data or materials that are not intended for you ii log or attempt to log into a server or account that you are not authorized to access or iii attempt to probe scan or test the vulnerability of the site violations of system or network security may result in civil or criminal liability cleveland biolabs reserves the right to investigate any suspected violation of this section and to involve and cooperate with law enforcement authorities in prosecuting any party who participates in any such violation compliance with laws you may use the site only for lawful purposes you agree that you will at all times comply with all applicable local state national and international laws statutes rules regulations ordinances and the like applicable to your use of the site disclaimers limitation of liability the site is provided “as is” and “as available” without warranties of any kind to the fullest extent permissible by law cleveland biolabs disclaims all warranties express implied or statutory including without limitation warranties of merchantability fitness for a particular purpose and noninfringement cleveland biolabs does not warrant that the site will be uninterrupted secure or errorfree that defects will be corrected or that the site or the server that makes it available are or will be free of viruses or other harmful components information included on the site may be incomplete outdated or inaccurate and may contain typographical errors cleveland biolabs makes no commitment to update the information included on the site your use of the site is at your own risk under no circumstances shall cleveland biolabs or any of its directors officers employees or agents be liable for any indirect special incidental consequential or exemplary damages including damages for loss of business revenue or profits and the like arising out of or in connection with your use of the site or your reliance on any information contained on the site whether based on contract negligence tort strict liability or any other basis even if cleveland biolabs has been advised of or should have known of the possibility of such damages because some jurisdictions do not permit the exclusion of certain warranties or the limitation of liability as set forth above such exclusions and limitations may not apply to you jurisdiction the information provided on the site is intended for united states audiences only cleveland biolabs makes no representation that the information on the site is appropriate or available for use in other locations and access or use of the site from territories in which the content of the site may be illegal is prohibited if you wish to access or use the site from outside of the united states you do so on your own initiative and you are responsible for complying with applicable laws and regulations you should not construe anything on the site as a promotion of or solicitation for any product or product candidate that is not authorized by the laws and regulations of the country in which you are located other agreements these terms of use set forth the terms and conditions upon which you may access and use the site and the information and content included on or made available through the site these terms of use do not modify alter or amend any other agreement that you may have or may enter into in the future with cleveland biolabs miscellaneous these terms of use constitute the entire agreement between you and cleveland biolabs with respect to your access to and use of the site and the information and content included on or made available through the site the failure of cleveland biolabs to exercise or enforce any right or provision of these terms of use shall not constitute a waiver of such right or provision if any provision of these terms of use is found by a court of competent jurisdiction to be invalid the remaining provisions of these terms of use shall remain in full force and effect privacy policy we respect the privacy of our visitors to our website the home page of which is located at wwwcbiolabscom this privacy policy is intended to inform you of our policies and practices regarding the collection use and disclosure of any personal information you submit to us through our website “personal information” is information about you that is personally identifiable like your name address email address or phone number and other information that is not otherwise publicly available user consent by submitting personal information through our website you agree to the terms of this privacy policy collection of personal information we collect personal information that you submit to us voluntarily through our website the types of information we collect are for visitors who email us directly via an email hyperlink email address any content included in the email for all visitors as you navigate our website certain passive information will also be collected including internet protocol addresses cookies and navigational data this type of information will be used for the purposes of gathering data to provide improved administration of our website and to improve the quality of your experience when interacting with our website use of personal information in general personal information you submit to us is used either to respond to requests that you make or to aid us in serving you better disclosure of personal information we do not sell your personal information or share your information with other companies or organizations without your consent the content of any communications you send to us is nonconfidential and we are under no obligation to refrain from reproducing publishing or otherwise using such content in any way or for any purpose we will not reproduce publish or otherwise use your personal information in connection with such content we may however reproduce or use your personal information in connection with any resume you submit to us for employment recruiting purposes we are free to use the content of any such communications excluding any resume you submit to us including any ideas inventions concepts techniques or knowhow disclosed therein for any purpose including developing manufacturing andor marketing goods or services although we currently do not have a parent company any subsidiaries joint ventures or other companies under a common control collectively “affiliates” we may in the future we may share some or all of your personal information with these affiliates in which case we will require our affiliates to honor this privacy policy if we are acquired by another company that company will possess the personal information collected by us and it will assume the rights and obligations regarding your personal information as described in this privacy policy regarding children our website is not designed for children under the age of  we will not deliberately gather personal information about visitors in this age group and do not collect any information on this website with respect to age links to other sites our provision of a link to any other website or location is for your convenience and does not signify our endorsement of such other website or location or its contents we have no control over do not review and cannot be responsible for these outside websites or their content please be aware that the terms of our privacy policy does not apply to these outside websites data security we use industrystandard methods to secure the communication of personal information from your computer to our servers in addition we use industrystandard methods of securing our databases of personal information including the use of firewalls except as provided elsewhere in this privacy policy we limit access to personal information databases to those persons in our organization who have a business need for such access you should know however that no company including cleveland biolabs can fully eliminate security risks associated with personal information contact us should you have any questions or concerns regarding this privacy policy please contact us cleveland biolabs inc  high st buffalo ny    privacy policy updates this privacy policy is subject to occasional revision and any changes will be posted on this site if you object to any such changes you must cease using our website continued use of our website following notice of any such changes shall indicate your acknowledgement of such changes and agreement to be bound by the terms and conditions of such changes this policy was last updated on june   about us history mission joint ventures alliances management team career opportunities pipeline entolimod cblb biodefense entolimod cblb oncology sa vaccine adjuvant cblb mobilan cbl discovery technology  scienceprotectan technology curaxin technology publications presentationsbusiness developmentlicensing opportunities investorspress releases stock quote and chart financials sec filings corporate governance management team  cleveland bio labs select page about us history mission joint ventures panacela alliances roswell park cancer institute cleveland clinic management team career opportunities executive management yakov kogan phd mba chief executive officer langdon miller md president chief medical officer andrei gudkov phd d sci chief scientific officer c neil lyons cpa executive vice president chief financial officer operational leadership ann hards phd executive vice president regulatory affairs andrei purmal phd vice president chemistry board of directors independent directors lea verny chairman randy s saluck alexander andryushechkin daniil talyanskiy anna evdokimova alexey nechaev ivan persiyanov advisors   steven grossman jd fda policy and public affairs advisor richard bittman phd regulatory affairs and biostatistics advisor homecontact usterms of useprivacy policy  cleveland biolabs all rights reserved headquarters cleveland biolabs inc  high street buffalo ny  tel  fax  view map terms of use the site has been designed to provide general information about cleveland biolabs inc the following terms of use set forth the terms and conditions upon which you may access and use the site and the information and content made available through the site please read them carefully by accessing or using the site you signify that you have read understand accept and agree to be bound by these terms of use and intend these terms of use to be the legal equivalent of a signed written contract if you do not accept and agree to be bound by these terms of use please do not access or use the site permission to use cleveland biolabs grants you a personal revocable nonexclusive nontransferable license to access and use the site in accordance with these terms of use your right to access and use the site is expressly conditioned on your continued compliance with these terms of use reservation of right to modify or terminate terms of use cleveland biolabs reserves the right to modify these terms of use or to impose new or additional terms of use at any time “modified terms” modified terms may be incorporated into these terms of use by any reasonable means including without limitation by posting them to the site your continued use of the site following the incorporation of any such modified terms shall be deemed conclusively to indicate your acceptance of all such modified terms in addition cleveland biolabs may in its sole discretion terminate these terms of use or your right to access the site at any time for any reason including without limitation improper use of the site or failure to adhere to these terms of use or for no reason termination of these terms of use will not affect in any way cleveland biolabs’ rights to relief at law or in equity intellectual property rights all content of the site is protected under united states copyright and trademark law as well as other state national and international laws and regulations you may download store print and copy selected information on the site for your personal noncommercial use provided that i all hard copies of any such information include all copyright and other applicable notices included with such information on the site ii you do not modify alter or adapt the content of the site in any way or delete or modify any copyright or trademark notice contained on the site and iii you do not reverse engineer decompile or disassemble any aspect of the site cleveland biolabs inc incuron panecela and other cleveland biolabs logos and product names included on the site are the trademarks of cleveland biolabs all other product and service names contained on the site if any are the trademarks or service marks of their respective owners except as expressly provided herein nothing in these terms of use or on the site shall be construed as granting any license or right to use any copyright trademark or other intellectual property right of cleveland biolabs by implication estoppel or otherwise all rights not expressly granted in these terms of use are hereby reserved certain site content any health or medical information included on the site is for informational purposes only and is not and is not intended to be a medical diagnosis or a replacement for advice given by a physician or other healthcare professional and none of the information included on the site constitutes or is intended to constitute investment advice product candidates in development described on the site have not been found safe or effective by any regulatory agency and are not approved for any use other than in certain clinical trials information included on the site regarding any product approved for marketing is qualified in its entirety by reference to the full prescribing information for such product thirdparty information the site may include certain thirdparty information or content this thirdparty information or content does not represent the views opinions or beliefs of cleveland biolabs and cleveland biolabs disclaims any responsibility for any such thirdparty information or content forwardlooking statements this site contains forwardlooking statements within the meaning of the private securities litigation reform act of  forwardlooking statements reflect management’s current expectations as of the date of this press release and involve certain risks and uncertainties the company’s actual results could differ materially from those anticipated in these forwardlooking statements as a result of various factors these factors include among others the company’s history of operating losses and the potential for future losses which may lead the company to not be able to continue as a going concern the company’s need for substantial additional financing to meet its business objectives the potential for the loss of funding from the company’s rd grants and contracts and its ability to win additional funding under such grants and contracts the company’s failure to successfully and timely develop new products the risks inherent in the early stages of drug development and in conducting clinical trials the company’s inability to obtain regulatory approval in a timely manner or at all the company’s collaborative relationships and the financial risks related thereto the company’s ability to comply with its obligations under license agreements the potential for significant product liability claims and the company’s ability to comply with various safety environmental and other governmental regulations some of these factors could cause future results to materially differ from the recent results or those projected in forwardlooking statements see also the “risk factors” and “forwardlooking statements” described in the company’s periodic filings with the securities and exchange commission submissions you may use the site to contact cleveland biolabs with inquiries about information included on the site when you provide any information to cleveland biolabs you agree to provide true accurate complete and current information and not to use a false or misleading name or a name that you are not authorized to use you shall not transmit information to or through the site that i infringes or violates any intellectual property right or privacy right of any third party or ii contains confidential information or trade secrets belonging to you or any third party cleveland biolabs does not want to receive any such information any ideas suggestions information knowhow material or other content transmitted to or through the site will be deemed to include a royaltyfree perpetual irrevocable transferable worldwide nonexclusive right and license for cleveland biolabs to adopt publish reproduce disseminate transmit distribute copy use create derivative works display in whole or part or act thereon without any approval or consideration from you in any form medium or technology now known or later developed for the full term of any rights that may exist therein cleveland biolabs makes no promise express or implied that it will not use any such idea suggestion information knowhow material or other content for its own purposes which may include reproduction publication broadcast and posting links the site may provide hypertext links to other web sites that are not owned or controlled by cleveland biolabs these links are provided for your convenience only these web sites are controlled by third parties that cleveland biolabs does not control accordingly cleveland biolabs expressly disclaims any responsibility for the content of such web sites for the accuracy or reliability of the information thereon and for the quality of products or services provided thereby or advertised thereon no link included on the site constitutes an endorsement of cleveland biolabs of any content of information on or product or service provided by or advertised on any such web site if you choose to hyperlink to another web site you do so at your own risk cleveland biolabs reserves the right to terminate any hypertext link without notice security you are prohibited from violating or attempting to violate the security of the site without limiting the generality of the foregoing you may not i access data or materials that are not intended for you ii log or attempt to log into a server or account that you are not authorized to access or iii attempt to probe scan or test the vulnerability of the site violations of system or network security may result in civil or criminal liability cleveland biolabs reserves the right to investigate any suspected violation of this section and to involve and cooperate with law enforcement authorities in prosecuting any party who participates in any such violation compliance with laws you may use the site only for lawful purposes you agree that you will at all times comply with all applicable local state national and international laws statutes rules regulations ordinances and the like applicable to your use of the site disclaimers limitation of liability the site is provided “as is” and “as available” without warranties of any kind to the fullest extent permissible by law cleveland biolabs disclaims all warranties express implied or statutory including without limitation warranties of merchantability fitness for a particular purpose and noninfringement cleveland biolabs does not warrant that the site will be uninterrupted secure or errorfree that defects will be corrected or that the site or the server that makes it available are or will be free of viruses or other harmful components information included on the site may be incomplete outdated or inaccurate and may contain typographical errors cleveland biolabs makes no commitment to update the information included on the site your use of the site is at your own risk under no circumstances shall cleveland biolabs or any of its directors officers employees or agents be liable for any indirect special incidental consequential or exemplary damages including damages for loss of business revenue or profits and the like arising out of or in connection with your use of the site or your reliance on any information contained on the site whether based on contract negligence tort strict liability or any other basis even if cleveland biolabs has been advised of or should have known of the possibility of such damages because some jurisdictions do not permit the exclusion of certain warranties or the limitation of liability as set forth above such exclusions and limitations may not apply to you jurisdiction the information provided on the site is intended for united states audiences only cleveland biolabs makes no representation that the information on the site is appropriate or available for use in other locations and access or use of the site from territories in which the content of the site may be illegal is prohibited if you wish to access or use the site from outside of the united states you do so on your own initiative and you are responsible for complying with applicable laws and regulations you should not construe anything on the site as a promotion of or solicitation for any product or product candidate that is not authorized by the laws and regulations of the country in which you are located other agreements these terms of use set forth the terms and conditions upon which you may access and use the site and the information and content included on or made available through the site these terms of use do not modify alter or amend any other agreement that you may have or may enter into in the future with cleveland biolabs miscellaneous these terms of use constitute the entire agreement between you and cleveland biolabs with respect to your access to and use of the site and the information and content included on or made available through the site the failure of cleveland biolabs to exercise or enforce any right or provision of these terms of use shall not constitute a waiver of such right or provision if any provision of these terms of use is found by a court of competent jurisdiction to be invalid the remaining provisions of these terms of use shall remain in full force and effect privacy policy we respect the privacy of our visitors to our website the home page of which is located at wwwcbiolabscom this privacy policy is intended to inform you of our policies and practices regarding the collection use and disclosure of any personal information you submit to us through our website “personal information” is information about you that is personally identifiable like your name address email address or phone number and other information that is not otherwise publicly available user consent by submitting personal information through our website you agree to the terms of this privacy policy collection of personal information we collect personal information that you submit to us voluntarily through our website the types of information we collect are for visitors who email us directly via an email hyperlink email address any content included in the email for all visitors as you navigate our website certain passive information will also be collected including internet protocol addresses cookies and navigational data this type of information will be used for the purposes of gathering data to provide improved administration of our website and to improve the quality of your experience when interacting with our website use of personal information in general personal information you submit to us is used either to respond to requests that you make or to aid us in serving you better disclosure of personal information we do not sell your personal information or share your information with other companies or organizations without your consent the content of any communications you send to us is nonconfidential and we are under no obligation to refrain from reproducing publishing or otherwise using such content in any way or for any purpose we will not reproduce publish or otherwise use your personal information in connection with such content we may however reproduce or use your personal information in connection with any resume you submit to us for employment recruiting purposes we are free to use the content of any such communications excluding any resume you submit to us including any ideas inventions concepts techniques or knowhow disclosed therein for any purpose including developing manufacturing andor marketing goods or services although we currently do not have a parent company any subsidiaries joint ventures or other companies under a common control collectively “affiliates” we may in the future we may share some or all of your personal information with these affiliates in which case we will require our affiliates to honor this privacy policy if we are acquired by another company that company will possess the personal information collected by us and it will assume the rights and obligations regarding your personal information as described in this privacy policy regarding children our website is not designed for children under the age of  we will not deliberately gather personal information about visitors in this age group and do not collect any information on this website with respect to age links to other sites our provision of a link to any other website or location is for your convenience and does not signify our endorsement of such other website or location or its contents we have no control over do not review and cannot be responsible for these outside websites or their content please be aware that the terms of our privacy policy does not apply to these outside websites data security we use industrystandard methods to secure the communication of personal information from your computer to our servers in addition we use industrystandard methods of securing our databases of personal information including the use of firewalls except as provided elsewhere in this privacy policy we limit access to personal information databases to those persons in our organization who have a business need for such access you should know however that no company including cleveland biolabs can fully eliminate security risks associated with personal information contact us should you have any questions or concerns regarding this privacy policy please contact us cleveland biolabs inc  high st buffalo ny    privacy policy updates this privacy policy is subject to occasional revision and any changes will be posted on this site if you object to any such changes you must cease using our website continued use of our website following notice of any such changes shall indicate your acknowledgement of such changes and agreement to be bound by the terms and conditions of such changes this policy was last updated on june   about us history mission joint ventures alliances management team career opportunities pipeline entolimod cblb biodefense entolimod cblb oncology sa vaccine adjuvant cblb mobilan cbl discovery technology  scienceprotectan technology curaxin technology publications presentationsbusiness developmentlicensing opportunities investorspress releases stock quote and chart financials sec filings corporate governance cblb  cleveland bio labs select page pipeline entolimod cblb biodefense presentations entolimod cblb oncology presentations sa vaccine adjuvnt cblb mobilan cbl presentations presentations discovery cblb cblb a clinicalstage investigational drug is a synthetic lipopeptide cblb activates nfkb prosurvival and immunoregulatory signaling pathways via specific binding to tolllike receptor  tlr on a subset of body tissues and cell types that express this receptor preclinical studies have shown that cblb stimulates white blood cell regeneration more recent research indicates that stimulation of these tolllike receptors may also enhance antitumor efficacy we believe an opportunity may exist for cblb to offer a singledose alternative to existing hemopoietic growth factors a phase  singlecenter blind placebocontrolled single ascendingdose study to evaluate the safety tolerability and pharmacodynamic effects of cblb in healthy volunteers was completed in the russian federation a phase  randomized placebocontrolled clinical study of cblb as myelosuppressive prophylaxis in patients with breast cancer receiving doxorubicincyclophosphamide chemotherapy was initiated in the russian federation homecontact usterms of useprivacy policy  cleveland biolabs all rights reserved headquarters cleveland biolabs inc  high street buffalo ny  tel  fax  view map terms of use the site has been designed to provide general information about cleveland biolabs inc the following terms of use set forth the terms and conditions upon which you may access and use the site and the information and content made available through the site please read them carefully by accessing or using the site you signify that you have read understand accept and agree to be bound by these terms of use and intend these terms of use to be the legal equivalent of a signed written contract if you do not accept and agree to be bound by these terms of use please do not access or use the site permission to use cleveland biolabs grants you a personal revocable nonexclusive nontransferable license to access and use the site in accordance with these terms of use your right to access and use the site is expressly conditioned on your continued compliance with these terms of use reservation of right to modify or terminate terms of use cleveland biolabs reserves the right to modify these terms of use or to impose new or additional terms of use at any time “modified terms” modified terms may be incorporated into these terms of use by any reasonable means including without limitation by posting them to the site your continued use of the site following the incorporation of any such modified terms shall be deemed conclusively to indicate your acceptance of all such modified terms in addition cleveland biolabs may in its sole discretion terminate these terms of use or your right to access the site at any time for any reason including without limitation improper use of the site or failure to adhere to these terms of use or for no reason termination of these terms of use will not affect in any way cleveland biolabs’ rights to relief at law or in equity intellectual property rights all content of the site is protected under united states copyright and trademark law as well as other state national and international laws and regulations you may download store print and copy selected information on the site for your personal noncommercial use provided that i all hard copies of any such information include all copyright and other applicable notices included with such information on the site ii you do not modify alter or adapt the content of the site in any way or delete or modify any copyright or trademark notice contained on the site and iii you do not reverse engineer decompile or disassemble any aspect of the site cleveland biolabs inc incuron panecela and other cleveland biolabs logos and product names included on the site are the trademarks of cleveland biolabs all other product and service names contained on the site if any are the trademarks or service marks of their respective owners except as expressly provided herein nothing in these terms of use or on the site shall be construed as granting any license or right to use any copyright trademark or other intellectual property right of cleveland biolabs by implication estoppel or otherwise all rights not expressly granted in these terms of use are hereby reserved certain site content any health or medical information included on the site is for informational purposes only and is not and is not intended to be a medical diagnosis or a replacement for advice given by a physician or other healthcare professional and none of the information included on the site constitutes or is intended to constitute investment advice product candidates in development described on the site have not been found safe or effective by any regulatory agency and are not approved for any use other than in certain clinical trials information included on the site regarding any product approved for marketing is qualified in its entirety by reference to the full prescribing information for such product thirdparty information the site may include certain thirdparty information or content this thirdparty information or content does not represent the views opinions or beliefs of cleveland biolabs and cleveland biolabs disclaims any responsibility for any such thirdparty information or content forwardlooking statements this site contains forwardlooking statements within the meaning of the private securities litigation reform act of  forwardlooking statements reflect management’s current expectations as of the date of this press release and involve certain risks and uncertainties the company’s actual results could differ materially from those anticipated in these forwardlooking statements as a result of various factors these factors include among others the company’s history of operating losses and the potential for future losses which may lead the company to not be able to continue as a going concern the company’s need for substantial additional financing to meet its business objectives the potential for the loss of funding from the company’s rd grants and contracts and its ability to win additional funding under such grants and contracts the company’s failure to successfully and timely develop new products the risks inherent in the early stages of drug development and in conducting clinical trials the company’s inability to obtain regulatory approval in a timely manner or at all the company’s collaborative relationships and the financial risks related thereto the company’s ability to comply with its obligations under license agreements the potential for significant product liability claims and the company’s ability to comply with various safety environmental and other governmental regulations some of these factors could cause future results to materially differ from the recent results or those projected in forwardlooking statements see also the “risk factors” and “forwardlooking statements” described in the company’s periodic filings with the securities and exchange commission submissions you may use the site to contact cleveland biolabs with inquiries about information included on the site when you provide any information to cleveland biolabs you agree to provide true accurate complete and current information and not to use a false or misleading name or a name that you are not authorized to use you shall not transmit information to or through the site that i infringes or violates any intellectual property right or privacy right of any third party or ii contains confidential information or trade secrets belonging to you or any third party cleveland biolabs does not want to receive any such information any ideas suggestions information knowhow material or other content transmitted to or through the site will be deemed to include a royaltyfree perpetual irrevocable transferable worldwide nonexclusive right and license for cleveland biolabs to adopt publish reproduce disseminate transmit distribute copy use create derivative works display in whole or part or act thereon without any approval or consideration from you in any form medium or technology now known or later developed for the full term of any rights that may exist therein cleveland biolabs makes no promise express or implied that it will not use any such idea suggestion information knowhow material or other content for its own purposes which may include reproduction publication broadcast and posting links the site may provide hypertext links to other web sites that are not owned or controlled by cleveland biolabs these links are provided for your convenience only these web sites are controlled by third parties that cleveland biolabs does not control accordingly cleveland biolabs expressly disclaims any responsibility for the content of such web sites for the accuracy or reliability of the information thereon and for the quality of products or services provided thereby or advertised thereon no link included on the site constitutes an endorsement of cleveland biolabs of any content of information on or product or service provided by or advertised on any such web site if you choose to hyperlink to another web site you do so at your own risk cleveland biolabs reserves the right to terminate any hypertext link without notice security you are prohibited from violating or attempting to violate the security of the site without limiting the generality of the foregoing you may not i access data or materials that are not intended for you ii log or attempt to log into a server or account that you are not authorized to access or iii attempt to probe scan or test the vulnerability of the site violations of system or network security may result in civil or criminal liability cleveland biolabs reserves the right to investigate any suspected violation of this section and to involve and cooperate with law enforcement authorities in prosecuting any party who participates in any such violation compliance with laws you may use the site only for lawful purposes you agree that you will at all times comply with all applicable local state national and international laws statutes rules regulations ordinances and the like applicable to your use of the site disclaimers limitation of liability the site is provided “as is” and “as available” without warranties of any kind to the fullest extent permissible by law cleveland biolabs disclaims all warranties express implied or statutory including without limitation warranties of merchantability fitness for a particular purpose and noninfringement cleveland biolabs does not warrant that the site will be uninterrupted secure or errorfree that defects will be corrected or that the site or the server that makes it available are or will be free of viruses or other harmful components information included on the site may be incomplete outdated or inaccurate and may contain typographical errors cleveland biolabs makes no commitment to update the information included on the site your use of the site is at your own risk under no circumstances shall cleveland biolabs or any of its directors officers employees or agents be liable for any indirect special incidental consequential or exemplary damages including damages for loss of business revenue or profits and the like arising out of or in connection with your use of the site or your reliance on any information contained on the site whether based on contract negligence tort strict liability or any other basis even if cleveland biolabs has been advised of or should have known of the possibility of such damages because some jurisdictions do not permit the exclusion of certain warranties or the limitation of liability as set forth above such exclusions and limitations may not apply to you jurisdiction the information provided on the site is intended for united states audiences only cleveland biolabs makes no representation that the information on the site is appropriate or available for use in other locations and access or use of the site from territories in which the content of the site may be illegal is prohibited if you wish to access or use the site from outside of the united states you do so on your own initiative and you are responsible for complying with applicable laws and regulations you should not construe anything on the site as a promotion of or solicitation for any product or product candidate that is not authorized by the laws and regulations of the country in which you are located other agreements these terms of use set forth the terms and conditions upon which you may access and use the site and the information and content included on or made available through the site these terms of use do not modify alter or amend any other agreement that you may have or may enter into in the future with cleveland biolabs miscellaneous these terms of use constitute the entire agreement between you and cleveland biolabs with respect to your access to and use of the site and the information and content included on or made available through the site the failure of cleveland biolabs to exercise or enforce any right or provision of these terms of use shall not constitute a waiver of such right or provision if any provision of these terms of use is found by a court of competent jurisdiction to be invalid the remaining provisions of these terms of use shall remain in full force and effect privacy policy we respect the privacy of our visitors to our website the home page of which is located at wwwcbiolabscom this privacy policy is intended to inform you of our policies and practices regarding the collection use and disclosure of any personal information you submit to us through our website “personal information” is information about you that is personally identifiable like your name address email address or phone number and other information that is not otherwise publicly available user consent by submitting personal information through our website you agree to the terms of this privacy policy collection of personal information we collect personal information that you submit to us voluntarily through our website the types of information we collect are for visitors who email us directly via an email hyperlink email address any content included in the email for all visitors as you navigate our website certain passive information will also be collected including internet protocol addresses cookies and navigational data this type of information will be used for the purposes of gathering data to provide improved administration of our website and to improve the quality of your experience when interacting with our website use of personal information in general personal information you submit to us is used either to respond to requests that you make or to aid us in serving you better disclosure of personal information we do not sell your personal information or share your information with other companies or organizations without your consent the content of any communications you send to us is nonconfidential and we are under no obligation to refrain from reproducing publishing or otherwise using such content in any way or for any purpose we will not reproduce publish or otherwise use your personal information in connection with such content we may however reproduce or use your personal information in connection with any resume you submit to us for employment recruiting purposes we are free to use the content of any such communications excluding any resume you submit to us including any ideas inventions concepts techniques or knowhow disclosed therein for any purpose including developing manufacturing andor marketing goods or services although we currently do not have a parent company any subsidiaries joint ventures or other companies under a common control collectively “affiliates” we may in the future we may share some or all of your personal information with these affiliates in which case we will require our affiliates to honor this privacy policy if we are acquired by another company that company will possess the personal information collected by us and it will assume the rights and obligations regarding your personal information as described in this privacy policy regarding children our website is not designed for children under the age of  we will not deliberately gather personal information about visitors in this age group and do not collect any information on this website with respect to age links to other sites our provision of a link to any other website or location is for your convenience and does not signify our endorsement of such other website or location or its contents we have no control over do not review and cannot be responsible for these outside websites or their content please be aware that the terms of our privacy policy does not apply to these outside websites data security we use industrystandard methods to secure the communication of personal information from your computer to our servers in addition we use industrystandard methods of securing our databases of personal information including the use of firewalls except as provided elsewhere in this privacy policy we limit access to personal information databases to those persons in our organization who have a business need for such access you should know however that no company including cleveland biolabs can fully eliminate security risks associated with personal information contact us should you have any questions or concerns regarding this privacy policy please contact us cleveland biolabs inc  high st buffalo ny    privacy policy updates this privacy policy is subject to occasional revision and any changes will be posted on this site if you object to any such changes you must cease using our website continued use of our website following notice of any such changes shall indicate your acknowledgement of such changes and agreement to be bound by the terms and conditions of such changes this policy was last updated on june   about us history mission joint ventures alliances management team career opportunities pipeline entolimod cblb biodefense entolimod cblb oncology sa vaccine adjuvant cblb mobilan cbl discovery technology  scienceprotectan technology curaxin technology publications presentationsbusiness developmentlicensing opportunities investorspress releases stock quote and chart financials sec filings corporate governance publications  cleveland bio labs select page technology and science protectan technology curaxin technology publications presentations publications protectan technology entolimod cblb  cblb  brackett cm koiouharov b veith j greene kf burdelya lg gollnick so abrams si gudkov av  tolllike receptor agonist entolimod suppresses metastasis and induces immunity by stimulating an nkdendriticcd tcell axis pnas  feb  pii  pmid   yang h brackett c moralestirado v li z zhang q wilson m benjamin c harris w waller v gudkov av burdelya l grossniklaus h  the tolllike receptor  agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an nk celldependent mechanism oncotarget  dec  doi oncotarget  krivokrysenko v toshkov i gleiberman a krasnov p shyshynova i bespalov i maitra r narizhneva n singh v whitnall m purmal a shakhov a gudkov av feinstein e  the tolllike receptor  agonist entolimod mitigates lethal acute radiation syndrome in nonhuman primates plos one sep e doi journalpone pmcid pmc  leigh nd bian g ding x liu h aygunsunar s burdelya lg gudkov av cao x  a flagellinderived tolllike receptor  agonist stimulates cytotoxic lymphocytemediated tumor immunity plos one jan e doi journalpone ecollection  pmid   kojouharov bm brackett cm veith jm johnson cp gitlin ii toshkov ia gleiberman asgudkov av burdelya lg  tolllike receptor agonist entolimod broadens the therapeutic window of fluorouracil by reducing its toxicity to normal tissues in mice oncotarget feb  pmid  chow cp faqi as developmental toxicity study of cblb in wistar rats reprod toxicol  jul doi jreprotox epub  mar  pmid   burdelya lg brackett cm kojouharov b gitlin ii leonova ki gleiberman as aygunsunar s veith j johnson c haderski gj stanhopebaker p allamaneni s skitzki j zeng m martsen e medvedev a scheblyakov d artemicheva nm logunov dy gintsburg al naroditsky bs makarov ss gudkov av central role of liver in anticancer and radioprotective activities of tolllike receptor  agonist proceedings of the national academy of science  may e doi pnas epub  apr  pmid   ding x bian g leigh nd qiu j mccarthy pl liu h aygunsunar s burdelya lg gudkov av cao x a tlr agonist enhances cd t cellmediated graftversustumor effect without exacerbating graftversushost disease j immunol  doi jimmunol epub  oct  pmid   krivokrysenko v shakhov a singh v bone f kononov y shyshynova i cheney a maitra r purmal a whitnall m gudkov av feinstein e  identification of gcsf and il as candidate biomarkers of cblb efficacy as a medical radiation countermeasure journal pharmacology and experimental therapeutics july  epub ahead of print pmid   yoon si kurnasov o natarajan v hong m gudkov av osterman al wilson ia  structural basis of tlrflagellin recognition and signaling science  pmid  • mueller k  flagellin takes its toll science editor’s choice  p ec  singh vk ducey ej fatanmi oo singh pk brown ds purmal a shakhova vv gudkov av feinstein e shakhov a  cblb a tlr agonist natural lipopeptide of mycoplasma arginini as a novel radiation countermeasure radiation research   pmid   shakhov an singh vk bone f cheney a kononov y krasnov p bratanovatoshkova tk shakhova vv young j weil mm panoskaltsismortari a orschell cm baker ps gudkov a feinstein e prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of tolllike receptor  tlr plos one e epub  mar pmid   burdelya lg gleiberman as toshkov i aygunsunar s bapardekar m manderscheidkern p bellnier d krivokrysenko vi feinstein e gudkov av  tolllike receptor  agonist protects mice from dermatitis and oral mucositis caused by local radiation implications for headandneck cancer radiotherapy international journal of radiation oncology biology and physics oct epub ahead of print pmid   fukuzawa n petro m baldwin wm rd gudkov av fairchild rl  a tlr agonist inhibits acute renal ischemic failure journal of immunology   pmid   burdelya lg krivokrysenko vi tallant tc strom e gleiberman as gupta d kurnasov ov fort fl osterman al didonato ja feinstein e gudkov av  an agonist of tolllike receptor  has radioprotective activity in mouse and primate models science  pmid  other supporting publications  howell ba siler sq shoda lk yang y woodhead jl watkins pb a mechanistic model of druginduced liver injury aids the interpretation of elevated liver transaminase levels in a phase i clinical trial cpt pharmacometrics syst pharmacol  feb e doi psp pmid   chen h wang zd chen ms zhang xq shen lp zhang jx chen y activation of tolllike receptors by intestinal microflora reduces radiationinduced dna damage in mice mutat res genet toxicol environ mutagen  nov  doijmrgentox epub  sep  pmid   hossain ms ramachandiran s gewirtz at waller ek recombinant tlr agonist cblb promotes nk cellmediated anticmv immunity in mice plos one  may e doi journalpone ecollection  pmid   lu j sun pd  the structure of the tlrflagellin complex a new mode of pathogen detection conserved receptor dimerization for signaling science signaling  pe  pmid   cai z sanchez a shi z zhang t liu m zhang d  activation of tolllike receptor  on breast cancer cells by flagellin suppresses cell proliferation and tumor growth cancer research doican pmid   gudkov av komarova ea  pathologies associated with the p response cold spring harb perspect biol a a epub  apr  pmid   bhattacharjee y  medicine drug bestows radiation resistance on mice and monkeys science  pmid   strom e sathe s komarov pg chernova ob pavlovska i shyshynova i bosykh da burdelya lg macklis rm skaliter r komarova ea gudkov av  small molecule inhibitor of p binding to mitochondria protects mice from gamma radiation nature chemical biology  july    pmid   komarova ea kondratov rv wang k christov k golovkina tv goldblum jr gudkov av  dual effect of p on radiation sensitivity in vivo p promotes hematopoietic injury but protects from gastrointestinal syndrome in mice oncogene   pmid   komarov pg komarova ea kondratov rv christovtselkov k coon js chernov mv gudkov av  a chemical inhibitor of p that protects mice from the side effects of cancer therapy science   pmid  curaxin technology cbl  predecessor  burkhart c fleyshman d kohrn r commane m garrigan j kurbatov v toshkov i ramachandran r martello l gurova kv  curaxin cbl eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer oncotarget nov  pmid   garcia h miecznikowski jc safina a commane m ruusulehto a kilpinen s leach rw attwood k li y degan s omilian ar guryanova o papantonopoulou o wang j buck m liu s morrison c gurova kv  facilitates chromatin transcription complex is an “accelerator” of tumor transformation and potential marker and target of aggressive cancers cell reports jul  pii sx doi jcelrep pmid   koman ie commane m paszkiewicz g hoonjan b pal s safina a toshkov i purmal aa wang d liu s morrison c gudkov av and gurova kv  targeting fact complex suppresses mammary tumorigenesis in herneu transgenic mice cancer prevention research aug pmid  gasparian av burkhart ca purmal aa brodsky l pal m saranadasa m bosykh da commane m guryanova oa pal s safina a sviridov s koman ie veith j komar aa gudkov av gurova kv curaxins anticancer compounds that simultaneously suppress nfkb and activate p by targeting fact science translational medicine ra pmid   gudkov av gurova kv komarova ea inflammation and p a tale of two stresses genes cancer  apr pmid   neznanov n gorbachev av neznanova l komarov ap gurova kv gasparian av banerjee ak almasan a fairchild rl gudkov av  antimalaria drug blocks proteotoxic stress response anticancer implications cell cycle  pmid   guo c gasparian av zhuang z bosykh da komar aa gudkov av gurova kv et al aminoacridinebased anticancer drugs target the pikaktmtor nfkappab and p pathways oncogene   pmid   gurova kv hill je guo c prokvolit a burdelya lg samoylova e khodyakova av ganapathi r ganapathi m tararova nd bosykh d lvovskiy d webb tr stark gr gudkov av  small molecules that reactivate p in renal cell carcinoma reveal a nfkappabdependent mechanism of p suppression in tumors proceedings of the national academy of science  pmid  other supporting publications  draetta gf depinho ra  cancer drug discovery faces the fact science translational medicine ps pmid   gasparian av neznanov n jha s galkin o moran jj gudkov av gurova kv komar aa  inhibition of encephalomyocarditis virus and poliovirus replication by quinacrine implications for the design and discovery of novel antiviral drugs journal of virology    pmid   mollapour m neckers l  quinacrine new antitumor application for an old antimalaria drug cell cycle  epub  jan  pmid   chau ch figg wd  new tricks from an old drug a role for quinacrine in anticancer therapy cell cycle  epub  dec  pmid   dai c whitesell l rogers ab lindquist s  heat shock factor  is a powerful multifaceted modifier of carcinogenesis cell   pmid   boiko ad porteous s razorenova ov krivokrysenko vi williams br gudkov av  a systematic search for downstream mediators of tumor suppressor function of p reveals a major role of btg in suppression of rasinduced transformation genes  development  pmid   komarova ea krivokrysenko v wang k neznanov n chernov mv komarov pg brennan ml golovkina tv rokhlin ow kuprash dv nedospasov sa hazen sl feinstein e gudkov av  p is a suppressor of inflammatory response in mice faseb journal  pmid  httpwwwncbinlmnihgovpubmed  gudkov av komarova ea  prospective therapeutic applications of p inhibitors biochemical and biophysical research communications   pmid  homecontact usterms of useprivacy policy  cleveland biolabs all rights reserved headquarters cleveland biolabs inc  high street buffalo ny  tel  fax  view map terms of use the site has been designed to provide general information about cleveland biolabs inc the following terms of use set forth the terms and conditions upon which you may access and use the site and the information and content made available through the site please read them carefully by accessing or using the site you signify that you have read understand accept and agree to be bound by these terms of use and intend these terms of use to be the legal equivalent of a signed written contract if you do not accept and agree to be bound by these terms of use please do not access or use the site permission to use cleveland biolabs grants you a personal revocable nonexclusive nontransferable license to access and use the site in accordance with these terms of use your right to access and use the site is expressly conditioned on your continued compliance with these terms of use reservation of right to modify or terminate terms of use cleveland biolabs reserves the right to modify these terms of use or to impose new or additional terms of use at any time “modified terms” modified terms may be incorporated into these terms of use by any reasonable means including without limitation by posting them to the site your continued use of the site following the incorporation of any such modified terms shall be deemed conclusively to indicate your acceptance of all such modified terms in addition cleveland biolabs may in its sole discretion terminate these terms of use or your right to access the site at any time for any reason including without limitation improper use of the site or failure to adhere to these terms of use or for no reason termination of these terms of use will not affect in any way cleveland biolabs’ rights to relief at law or in equity intellectual property rights all content of the site is protected under united states copyright and trademark law as well as other state national and international laws and regulations you may download store print and copy selected information on the site for your personal noncommercial use provided that i all hard copies of any such information include all copyright and other applicable notices included with such information on the site ii you do not modify alter or adapt the content of the site in any way or delete or modify any copyright or trademark notice contained on the site and iii you do not reverse engineer decompile or disassemble any aspect of the site cleveland biolabs inc incuron panecela and other cleveland biolabs logos and product names included on the site are the trademarks of cleveland biolabs all other product and service names contained on the site if any are the trademarks or service marks of their respective owners except as expressly provided herein nothing in these terms of use or on the site shall be construed as granting any license or right to use any copyright trademark or other intellectual property right of cleveland biolabs by implication estoppel or otherwise all rights not expressly granted in these terms of use are hereby reserved certain site content any health or medical information included on the site is for informational purposes only and is not and is not intended to be a medical diagnosis or a replacement for advice given by a physician or other healthcare professional and none of the information included on the site constitutes or is intended to constitute investment advice product candidates in development described on the site have not been found safe or effective by any regulatory agency and are not approved for any use other than in certain clinical trials information included on the site regarding any product approved for marketing is qualified in its entirety by reference to the full prescribing information for such product thirdparty information the site may include certain thirdparty information or content this thirdparty information or content does not represent the views opinions or beliefs of cleveland biolabs and cleveland biolabs disclaims any responsibility for any such thirdparty information or content forwardlooking statements this site contains forwardlooking statements within the meaning of the private securities litigation reform act of  forwardlooking statements reflect management’s current expectations as of the date of this press release and involve certain risks and uncertainties the company’s actual results could differ materially from those anticipated in these forwardlooking statements as a result of various factors these factors include among others the company’s history of operating losses and the potential for future losses which may lead the company to not be able to continue as a going concern the company’s need for substantial additional financing to meet its business objectives the potential for the loss of funding from the company’s rd grants and contracts and its ability to win additional funding under such grants and contracts the company’s failure to successfully and timely develop new products the risks inherent in the early stages of drug development and in conducting clinical trials the company’s inability to obtain regulatory approval in a timely manner or at all the company’s collaborative relationships and the financial risks related thereto the company’s ability to comply with its obligations under license agreements the potential for significant product liability claims and the company’s ability to comply with various safety environmental and other governmental regulations some of these factors could cause future results to materially differ from the recent results or those projected in forwardlooking statements see also the “risk factors” and “forwardlooking statements” described in the company’s periodic filings with the securities and exchange commission submissions you may use the site to contact cleveland biolabs with inquiries about information included on the site when you provide any information to cleveland biolabs you agree to provide true accurate complete and current information and not to use a false or misleading name or a name that you are not authorized to use you shall not transmit information to or through the site that i infringes or violates any intellectual property right or privacy right of any third party or ii contains confidential information or trade secrets belonging to you or any third party cleveland biolabs does not want to receive any such information any ideas suggestions information knowhow material or other content transmitted to or through the site will be deemed to include a royaltyfree perpetual irrevocable transferable worldwide nonexclusive right and license for cleveland biolabs to adopt publish reproduce disseminate transmit distribute copy use create derivative works display in whole or part or act thereon without any approval or consideration from you in any form medium or technology now known or later developed for the full term of any rights that may exist therein cleveland biolabs makes no promise express or implied that it will not use any such idea suggestion information knowhow material or other content for its own purposes which may include reproduction publication broadcast and posting links the site may provide hypertext links to other web sites that are not owned or controlled by cleveland biolabs these links are provided for your convenience only these web sites are controlled by third parties that cleveland biolabs does not control accordingly cleveland biolabs expressly disclaims any responsibility for the content of such web sites for the accuracy or reliability of the information thereon and for the quality of products or services provided thereby or advertised thereon no link included on the site constitutes an endorsement of cleveland biolabs of any content of information on or product or service provided by or advertised on any such web site if you choose to hyperlink to another web site you do so at your own risk cleveland biolabs reserves the right to terminate any hypertext link without notice security you are prohibited from violating or attempting to violate the security of the site without limiting the generality of the foregoing you may not i access data or materials that are not intended for you ii log or attempt to log into a server or account that you are not authorized to access or iii attempt to probe scan or test the vulnerability of the site violations of system or network security may result in civil or criminal liability cleveland biolabs reserves the right to investigate any suspected violation of this section and to involve and cooperate with law enforcement authorities in prosecuting any party who participates in any such violation compliance with laws you may use the site only for lawful purposes you agree that you will at all times comply with all applicable local state national and international laws statutes rules regulations ordinances and the like applicable to your use of the site disclaimers limitation of liability the site is provided “as is” and “as available” without warranties of any kind to the fullest extent permissible by law cleveland biolabs disclaims all warranties express implied or statutory including without limitation warranties of merchantability fitness for a particular purpose and noninfringement cleveland biolabs does not warrant that the site will be uninterrupted secure or errorfree that defects will be corrected or that the site or the server that makes it available are or will be free of viruses or other harmful components information included on the site may be incomplete outdated or inaccurate and may contain typographical errors cleveland biolabs makes no commitment to update the information included on the site your use of the site is at your own risk under no circumstances shall cleveland biolabs or any of its directors officers employees or agents be liable for any indirect special incidental consequential or exemplary damages including damages for loss of business revenue or profits and the like arising out of or in connection with your use of the site or your reliance on any information contained on the site whether based on contract negligence tort strict liability or any other basis even if cleveland biolabs has been advised of or should have known of the possibility of such damages because some jurisdictions do not permit the exclusion of certain warranties or the limitation of liability as set forth above such exclusions and limitations may not apply to you jurisdiction the information provided on the site is intended for united states audiences only cleveland biolabs makes no representation that the information on the site is appropriate or available for use in other locations and access or use of the site from territories in which the content of the site may be illegal is prohibited if you wish to access or use the site from outside of the united states you do so on your own initiative and you are responsible for complying with applicable laws and regulations you should not construe anything on the site as a promotion of or solicitation for any product or product candidate that is not authorized by the laws and regulations of the country in which you are located other agreements these terms of use set forth the terms and conditions upon which you may access and use the site and the information and content included on or made available through the site these terms of use do not modify alter or amend any other agreement that you may have or may enter into in the future with cleveland biolabs miscellaneous these terms of use constitute the entire agreement between you and cleveland biolabs with respect to your access to and use of the site and the information and content included on or made available through the site the failure of cleveland biolabs to exercise or enforce any right or provision of these terms of use shall not constitute a waiver of such right or provision if any provision of these terms of use is found by a court of competent jurisdiction to be invalid the remaining provisions of these terms of use shall remain in full force and effect privacy policy we respect the privacy of our visitors to our website the home page of which is located at wwwcbiolabscom this privacy policy is intended to inform you of our policies and practices regarding the collection use and disclosure of any personal information you submit to us through our website “personal information” is information about you that is personally identifiable like your name address email address or phone number and other information that is not otherwise publicly available user consent by submitting personal information through our website you agree to the terms of this privacy policy collection of personal information we collect personal information that you submit to us voluntarily through our website the types of information we collect are for visitors who email us directly via an email hyperlink email address any content included in the email for all visitors as you navigate our website certain passive information will also be collected including internet protocol addresses cookies and navigational data this type of information will be used for the purposes of gathering data to provide improved administration of our website and to improve the quality of your experience when interacting with our website use of personal information in general personal information you submit to us is used either to respond to requests that you make or to aid us in serving you better disclosure of personal information we do not sell your personal information or share your information with other companies or organizations without your consent the content of any communications you send to us is nonconfidential and we are under no obligation to refrain from reproducing publishing or otherwise using such content in any way or for any purpose we will not reproduce publish or otherwise use your personal information in connection with such content we may however reproduce or use your personal information in connection with any resume you submit to us for employment recruiting purposes we are free to use the content of any such communications excluding any resume you submit to us including any ideas inventions concepts techniques or knowhow disclosed therein for any purpose including developing manufacturing andor marketing goods or services although we currently do not have a parent company any subsidiaries joint ventures or other companies under a common control collectively “affiliates” we may in the future we may share some or all of your personal information with these affiliates in which case we will require our affiliates to honor this privacy policy if we are acquired by another company that company will possess the personal information collected by us and it will assume the rights and obligations regarding your personal information as described in this privacy policy regarding children our website is not designed for children under the age of  we will not deliberately gather personal information about visitors in this age group and do not collect any information on this website with respect to age links to other sites our provision of a link to any other website or location is for your convenience and does not signify our endorsement of such other website or location or its contents we have no control over do not review and cannot be responsible for these outside websites or their content please be aware that the terms of our privacy policy does not apply to these outside websites data security we use industrystandard methods to secure the communication of personal information from your computer to our servers in addition we use industrystandard methods of securing our databases of personal information including the use of firewalls except as provided elsewhere in this privacy policy we limit access to personal information databases to those persons in our organization who have a business need for such access you should know however that no company including cleveland biolabs can fully eliminate security risks associated with personal information contact us should you have any questions or concerns regarding this privacy policy please contact us cleveland biolabs inc  high st buffalo ny    privacy policy updates this privacy policy is subject to occasional revision and any changes will be posted on this site if you object to any such changes you must cease using our website continued use of our website following notice of any such changes shall indicate your acknowledgement of such changes and agreement to be bound by the terms and conditions of such changes this policy was last updated on june   about us history mission joint ventures alliances management team career opportunities pipeline entolimod cblb biodefense entolimod cblb oncology sa vaccine adjuvant cblb mobilan cbl discovery technology  scienceprotectan technology curaxin technology publications presentationsbusiness developmentlicensing opportunities investorspress releases stock quote and chart financials sec filings corporate governance overview  cleveland bio labs select page about us history mission joint ventures panacela alliances roswell park cancer institute cleveland clinic management team career opportunities corporate overview cleveland biolabs inc nasdaq cbli cleveland biolabs inc nasdaq cbli is an innovative biopharmaceutical company developing novel approaches to activate the immune system and address serious medical needs our proprietary platform of tolllike immune receptor activators has applications in radiation mitigation oncology immunotherapy and vaccines we combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells homecontact usterms of useprivacy policy  cleveland biolabs all rights reserved headquarters cleveland biolabs inc  high street buffalo ny  tel  fax  view map terms of use the site has been designed to provide general information about cleveland biolabs inc the following terms of use set forth the terms and conditions upon which you may access and use the site and the information and content made available through the site please read them carefully by accessing or using the site you signify that you have read understand accept and agree to be bound by these terms of use and intend these terms of use to be the legal equivalent of a signed written contract if you do not accept and agree to be bound by these terms of use please do not access or use the site permission to use cleveland biolabs grants you a personal revocable nonexclusive nontransferable license to access and use the site in accordance with these terms of use your right to access and use the site is expressly conditioned on your continued compliance with these terms of use reservation of right to modify or terminate terms of use cleveland biolabs reserves the right to modify these terms of use or to impose new or additional terms of use at any time “modified terms” modified terms may be incorporated into these terms of use by any reasonable means including without limitation by posting them to the site your continued use of the site following the incorporation of any such modified terms shall be deemed conclusively to indicate your acceptance of all such modified terms in addition cleveland biolabs may in its sole discretion terminate these terms of use or your right to access the site at any time for any reason including without limitation improper use of the site or failure to adhere to these terms of use or for no reason termination of these terms of use will not affect in any way cleveland biolabs’ rights to relief at law or in equity intellectual property rights all content of the site is protected under united states copyright and trademark law as well as other state national and international laws and regulations you may download store print and copy selected information on the site for your personal noncommercial use provided that i all hard copies of any such information include all copyright and other applicable notices included with such information on the site ii you do not modify alter or adapt the content of the site in any way or delete or modify any copyright or trademark notice contained on the site and iii you do not reverse engineer decompile or disassemble any aspect of the site cleveland biolabs inc incuron panecela and other cleveland biolabs logos and product names included on the site are the trademarks of cleveland biolabs all other product and service names contained on the site if any are the trademarks or service marks of their respective owners except as expressly provided herein nothing in these terms of use or on the site shall be construed as granting any license or right to use any copyright trademark or other intellectual property right of cleveland biolabs by implication estoppel or otherwise all rights not expressly granted in these terms of use are hereby reserved certain site content any health or medical information included on the site is for informational purposes only and is not and is not intended to be a medical diagnosis or a replacement for advice given by a physician or other healthcare professional and none of the information included on the site constitutes or is intended to constitute investment advice product candidates in development described on the site have not been found safe or effective by any regulatory agency and are not approved for any use other than in certain clinical trials information included on the site regarding any product approved for marketing is qualified in its entirety by reference to the full prescribing information for such product thirdparty information the site may include certain thirdparty information or content this thirdparty information or content does not represent the views opinions or beliefs of cleveland biolabs and cleveland biolabs disclaims any responsibility for any such thirdparty information or content forwardlooking statements this site contains forwardlooking statements within the meaning of the private securities litigation reform act of  forwardlooking statements reflect management’s current expectations as of the date of this press release and involve certain risks and uncertainties the company’s actual results could differ materially from those anticipated in these forwardlooking statements as a result of various factors these factors include among others the company’s history of operating losses and the potential for future losses which may lead the company to not be able to continue as a going concern the company’s need for substantial additional financing to meet its business objectives the potential for the loss of funding from the company’s rd grants and contracts and its ability to win additional funding under such grants and contracts the company’s failure to successfully and timely develop new products the risks inherent in the early stages of drug development and in conducting clinical trials the company’s inability to obtain regulatory approval in a timely manner or at all the company’s collaborative relationships and the financial risks related thereto the company’s ability to comply with its obligations under license agreements the potential for significant product liability claims and the company’s ability to comply with various safety environmental and other governmental regulations some of these factors could cause future results to materially differ from the recent results or those projected in forwardlooking statements see also the “risk factors” and “forwardlooking statements” described in the company’s periodic filings with the securities and exchange commission submissions you may use the site to contact cleveland biolabs with inquiries about information included on the site when you provide any information to cleveland biolabs you agree to provide true accurate complete and current information and not to use a false or misleading name or a name that you are not authorized to use you shall not transmit information to or through the site that i infringes or violates any intellectual property right or privacy right of any third party or ii contains confidential information or trade secrets belonging to you or any third party cleveland biolabs does not want to receive any such information any ideas suggestions information knowhow material or other content transmitted to or through the site will be deemed to include a royaltyfree perpetual irrevocable transferable worldwide nonexclusive right and license for cleveland biolabs to adopt publish reproduce disseminate transmit distribute copy use create derivative works display in whole or part or act thereon without any approval or consideration from you in any form medium or technology now known or later developed for the full term of any rights that may exist therein cleveland biolabs makes no promise express or implied that it will not use any such idea suggestion information knowhow material or other content for its own purposes which may include reproduction publication broadcast and posting links the site may provide hypertext links to other web sites that are not owned or controlled by cleveland biolabs these links are provided for your convenience only these web sites are controlled by third parties that cleveland biolabs does not control accordingly cleveland biolabs expressly disclaims any responsibility for the content of such web sites for the accuracy or reliability of the information thereon and for the quality of products or services provided thereby or advertised thereon no link included on the site constitutes an endorsement of cleveland biolabs of any content of information on or product or service provided by or advertised on any such web site if you choose to hyperlink to another web site you do so at your own risk cleveland biolabs reserves the right to terminate any hypertext link without notice security you are prohibited from violating or attempting to violate the security of the site without limiting the generality of the foregoing you may not i access data or materials that are not intended for you ii log or attempt to log into a server or account that you are not authorized to access or iii attempt to probe scan or test the vulnerability of the site violations of system or network security may result in civil or criminal liability cleveland biolabs reserves the right to investigate any suspected violation of this section and to involve and cooperate with law enforcement authorities in prosecuting any party who participates in any such violation compliance with laws you may use the site only for lawful purposes you agree that you will at all times comply with all applicable local state national and international laws statutes rules regulations ordinances and the like applicable to your use of the site disclaimers limitation of liability the site is provided “as is” and “as available” without warranties of any kind to the fullest extent permissible by law cleveland biolabs disclaims all warranties express implied or statutory including without limitation warranties of merchantability fitness for a particular purpose and noninfringement cleveland biolabs does not warrant that the site will be uninterrupted secure or errorfree that defects will be corrected or that the site or the server that makes it available are or will be free of viruses or other harmful components information included on the site may be incomplete outdated or inaccurate and may contain typographical errors cleveland biolabs makes no commitment to update the information included on the site your use of the site is at your own risk under no circumstances shall cleveland biolabs or any of its directors officers employees or agents be liable for any indirect special incidental consequential or exemplary damages including damages for loss of business revenue or profits and the like arising out of or in connection with your use of the site or your reliance on any information contained on the site whether based on contract negligence tort strict liability or any other basis even if cleveland biolabs has been advised of or should have known of the possibility of such damages because some jurisdictions do not permit the exclusion of certain warranties or the limitation of liability as set forth above such exclusions and limitations may not apply to you jurisdiction the information provided on the site is intended for united states audiences only cleveland biolabs makes no representation that the information on the site is appropriate or available for use in other locations and access or use of the site from territories in which the content of the site may be illegal is prohibited if you wish to access or use the site from outside of the united states you do so on your own initiative and you are responsible for complying with applicable laws and regulations you should not construe anything on the site as a promotion of or solicitation for any product or product candidate that is not authorized by the laws and regulations of the country in which you are located other agreements these terms of use set forth the terms and conditions upon which you may access and use the site and the information and content included on or made available through the site these terms of use do not modify alter or amend any other agreement that you may have or may enter into in the future with cleveland biolabs miscellaneous these terms of use constitute the entire agreement between you and cleveland biolabs with respect to your access to and use of the site and the information and content included on or made available through the site the failure of cleveland biolabs to exercise or enforce any right or provision of these terms of use shall not constitute a waiver of such right or provision if any provision of these terms of use is found by a court of competent jurisdiction to be invalid the remaining provisions of these terms of use shall remain in full force and effect privacy policy we respect the privacy of our visitors to our website the home page of which is located at wwwcbiolabscom this privacy policy is intended to inform you of our policies and practices regarding the collection use and disclosure of any personal information you submit to us through our website “personal information” is information about you that is personally identifiable like your name address email address or phone number and other information that is not otherwise publicly available user consent by submitting personal information through our website you agree to the terms of this privacy policy collection of personal information we collect personal information that you submit to us voluntarily through our website the types of information we collect are for visitors who email us directly via an email hyperlink email address any content included in the email for all visitors as you navigate our website certain passive information will also be collected including internet protocol addresses cookies and navigational data this type of information will be used for the purposes of gathering data to provide improved administration of our website and to improve the quality of your experience when interacting with our website use of personal information in general personal information you submit to us is used either to respond to requests that you make or to aid us in serving you better disclosure of personal information we do not sell your personal information or share your information with other companies or organizations without your consent the content of any communications you send to us is nonconfidential and we are under no obligation to refrain from reproducing publishing or otherwise using such content in any way or for any purpose we will not reproduce publish or otherwise use your personal information in connection with such content we may however reproduce or use your personal information in connection with any resume you submit to us for employment recruiting purposes we are free to use the content of any such communications excluding any resume you submit to us including any ideas inventions concepts techniques or knowhow disclosed therein for any purpose including developing manufacturing andor marketing goods or services although we currently do not have a parent company any subsidiaries joint ventures or other companies under a common control collectively “affiliates” we may in the future we may share some or all of your personal information with these affiliates in which case we will require our affiliates to honor this privacy policy if we are acquired by another company that company will possess the personal information collected by us and it will assume the rights and obligations regarding your personal information as described in this privacy policy regarding children our website is not designed for children under the age of  we will not deliberately gather personal information about visitors in this age group and do not collect any information on this website with respect to age links to other sites our provision of a link to any other website or location is for your convenience and does not signify our endorsement of such other website or location or its contents we have no control over do not review and cannot be responsible for these outside websites or their content please be aware that the terms of our privacy policy does not apply to these outside websites data security we use industrystandard methods to secure the communication of personal information from your computer to our servers in addition we use industrystandard methods of securing our databases of personal information including the use of firewalls except as provided elsewhere in this privacy policy we limit access to personal information databases to those persons in our organization who have a business need for such access you should know however that no company including cleveland biolabs can fully eliminate security risks associated with personal information contact us should you have any questions or concerns regarding this privacy policy please contact us cleveland biolabs inc  high st buffalo ny    privacy policy updates this privacy policy is subject to occasional revision and any changes will be posted on this site if you object to any such changes you must cease using our website continued use of our website following notice of any such changes shall indicate your acknowledgement of such changes and agreement to be bound by the terms and conditions of such changes this policy was last updated on june   about us history mission joint ventures alliances management team career opportunities pipeline entolimod cblb biodefense entolimod cblb oncology sa vaccine adjuvant cblb mobilan cbl discovery technology  scienceprotectan technology curaxin technology publications presentationsbusiness developmentlicensing opportunities investorspress releases stock quote and chart financials sec filings corporate governance about us  cleveland bio labs select page about us history mission joint ventures panacela alliances roswell park cancer institute cleveland clinic management team career opportunities about us cleveland biolabs inc nasdaq cbli is an innovative biopharmaceutical company developing novel approaches to activate the immune system and address serious medical needs our proprietary platform of tolllike immune receptor activators has applications in radiation mitigation oncology immunotherapy and vaccines we combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells our most advanced product candidate is entolimod which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications we have additional pipeline product candidates in various stages of development homecontact usterms of useprivacy policy  cleveland biolabs all rights reserved headquarters cleveland biolabs inc  high street buffalo ny  tel  fax  view map terms of use the site has been designed to provide general information about cleveland biolabs inc the following terms of use set forth the terms and conditions upon which you may access and use the site and the information and content made available through the site please read them carefully by accessing or using the site you signify that you have read understand accept and agree to be bound by these terms of use and intend these terms of use to be the legal equivalent of a signed written contract if you do not accept and agree to be bound by these terms of use please do not access or use the site permission to use cleveland biolabs grants you a personal revocable nonexclusive nontransferable license to access and use the site in accordance with these terms of use your right to access and use the site is expressly conditioned on your continued compliance with these terms of use reservation of right to modify or terminate terms of use cleveland biolabs reserves the right to modify these terms of use or to impose new or additional terms of use at any time “modified terms” modified terms may be incorporated into these terms of use by any reasonable means including without limitation by posting them to the site your continued use of the site following the incorporation of any such modified terms shall be deemed conclusively to indicate your acceptance of all such modified terms in addition cleveland biolabs may in its sole discretion terminate these terms of use or your right to access the site at any time for any reason including without limitation improper use of the site or failure to adhere to these terms of use or for no reason termination of these terms of use will not affect in any way cleveland biolabs’ rights to relief at law or in equity intellectual property rights all content of the site is protected under united states copyright and trademark law as well as other state national and international laws and regulations you may download store print and copy selected information on the site for your personal noncommercial use provided that i all hard copies of any such information include all copyright and other applicable notices included with such information on the site ii you do not modify alter or adapt the content of the site in any way or delete or modify any copyright or trademark notice contained on the site and iii you do not reverse engineer decompile or disassemble any aspect of the site cleveland biolabs inc incuron panecela and other cleveland biolabs logos and product names included on the site are the trademarks of cleveland biolabs all other product and service names contained on the site if any are the trademarks or service marks of their respective owners except as expressly provided herein nothing in these terms of use or on the site shall be construed as granting any license or right to use any copyright trademark or other intellectual property right of cleveland biolabs by implication estoppel or otherwise all rights not expressly granted in these terms of use are hereby reserved certain site content any health or medical information included on the site is for informational purposes only and is not and is not intended to be a medical diagnosis or a replacement for advice given by a physician or other healthcare professional and none of the information included on the site constitutes or is intended to constitute investment advice product candidates in development described on the site have not been found safe or effective by any regulatory agency and are not approved for any use other than in certain clinical trials information included on the site regarding any product approved for marketing is qualified in its entirety by reference to the full prescribing information for such product thirdparty information the site may include certain thirdparty information or content this thirdparty information or content does not represent the views opinions or beliefs of cleveland biolabs and cleveland biolabs disclaims any responsibility for any such thirdparty information or content forwardlooking statements this site contains forwardlooking statements within the meaning of the private securities litigation reform act of  forwardlooking statements reflect management’s current expectations as of the date of this press release and involve certain risks and uncertainties the company’s actual results could differ materially from those anticipated in these forwardlooking statements as a result of various factors these factors include among others the company’s history of operating losses and the potential for future losses which may lead the company to not be able to continue as a going concern the company’s need for substantial additional financing to meet its business objectives the potential for the loss of funding from the company’s rd grants and contracts and its ability to win additional funding under such grants and contracts the company’s failure to successfully and timely develop new products the risks inherent in the early stages of drug development and in conducting clinical trials the company’s inability to obtain regulatory approval in a timely manner or at all the company’s collaborative relationships and the financial risks related thereto the company’s ability to comply with its obligations under license agreements the potential for significant product liability claims and the company’s ability to comply with various safety environmental and other governmental regulations some of these factors could cause future results to materially differ from the recent results or those projected in forwardlooking statements see also the “risk factors” and “forwardlooking statements” described in the company’s periodic filings with the securities and exchange commission submissions you may use the site to contact cleveland biolabs with inquiries about information included on the site when you provide any information to cleveland biolabs you agree to provide true accurate complete and current information and not to use a false or misleading name or a name that you are not authorized to use you shall not transmit information to or through the site that i infringes or violates any intellectual property right or privacy right of any third party or ii contains confidential information or trade secrets belonging to you or any third party cleveland biolabs does not want to receive any such information any ideas suggestions information knowhow material or other content transmitted to or through the site will be deemed to include a royaltyfree perpetual irrevocable transferable worldwide nonexclusive right and license for cleveland biolabs to adopt publish reproduce disseminate transmit distribute copy use create derivative works display in whole or part or act thereon without any approval or consideration from you in any form medium or technology now known or later developed for the full term of any rights that may exist therein cleveland biolabs makes no promise express or implied that it will not use any such idea suggestion information knowhow material or other content for its own purposes which may include reproduction publication broadcast and posting links the site may provide hypertext links to other web sites that are not owned or controlled by cleveland biolabs these links are provided for your convenience only these web sites are controlled by third parties that cleveland biolabs does not control accordingly cleveland biolabs expressly disclaims any responsibility for the content of such web sites for the accuracy or reliability of the information thereon and for the quality of products or services provided thereby or advertised thereon no link included on the site constitutes an endorsement of cleveland biolabs of any content of information on or product or service provided by or advertised on any such web site if you choose to hyperlink to another web site you do so at your own risk cleveland biolabs reserves the right to terminate any hypertext link without notice security you are prohibited from violating or attempting to violate the security of the site without limiting the generality of the foregoing you may not i access data or materials that are not intended for you ii log or attempt to log into a server or account that you are not authorized to access or iii attempt to probe scan or test the vulnerability of the site violations of system or network security may result in civil or criminal liability cleveland biolabs reserves the right to investigate any suspected violation of this section and to involve and cooperate with law enforcement authorities in prosecuting any party who participates in any such violation compliance with laws you may use the site only for lawful purposes you agree that you will at all times comply with all applicable local state national and international laws statutes rules regulations ordinances and the like applicable to your use of the site disclaimers limitation of liability the site is provided “as is” and “as available” without warranties of any kind to the fullest extent permissible by law cleveland biolabs disclaims all warranties express implied or statutory including without limitation warranties of merchantability fitness for a particular purpose and noninfringement cleveland biolabs does not warrant that the site will be uninterrupted secure or errorfree that defects will be corrected or that the site or the server that makes it available are or will be free of viruses or other harmful components information included on the site may be incomplete outdated or inaccurate and may contain typographical errors cleveland biolabs makes no commitment to update the information included on the site your use of the site is at your own risk under no circumstances shall cleveland biolabs or any of its directors officers employees or agents be liable for any indirect special incidental consequential or exemplary damages including damages for loss of business revenue or profits and the like arising out of or in connection with your use of the site or your reliance on any information contained on the site whether based on contract negligence tort strict liability or any other basis even if cleveland biolabs has been advised of or should have known of the possibility of such damages because some jurisdictions do not permit the exclusion of certain warranties or the limitation of liability as set forth above such exclusions and limitations may not apply to you jurisdiction the information provided on the site is intended for united states audiences only cleveland biolabs makes no representation that the information on the site is appropriate or available for use in other locations and access or use of the site from territories in which the content of the site may be illegal is prohibited if you wish to access or use the site from outside of the united states you do so on your own initiative and you are responsible for complying with applicable laws and regulations you should not construe anything on the site as a promotion of or solicitation for any product or product candidate that is not authorized by the laws and regulations of the country in which you are located other agreements these terms of use set forth the terms and conditions upon which you may access and use the site and the information and content included on or made available through the site these terms of use do not modify alter or amend any other agreement that you may have or may enter into in the future with cleveland biolabs miscellaneous these terms of use constitute the entire agreement between you and cleveland biolabs with respect to your access to and use of the site and the information and content included on or made available through the site the failure of cleveland biolabs to exercise or enforce any right or provision of these terms of use shall not constitute a waiver of such right or provision if any provision of these terms of use is found by a court of competent jurisdiction to be invalid the remaining provisions of these terms of use shall remain in full force and effect privacy policy we respect the privacy of our visitors to our website the home page of which is located at wwwcbiolabscom this privacy policy is intended to inform you of our policies and practices regarding the collection use and disclosure of any personal information you submit to us through our website “personal information” is information about you that is personally identifiable like your name address email address or phone number and other information that is not otherwise publicly available user consent by submitting personal information through our website you agree to the terms of this privacy policy collection of personal information we collect personal information that you submit to us voluntarily through our website the types of information we collect are for visitors who email us directly via an email hyperlink email address any content included in the email for all visitors as you navigate our website certain passive information will also be collected including internet protocol addresses cookies and navigational data this type of information will be used for the purposes of gathering data to provide improved administration of our website and to improve the quality of your experience when interacting with our website use of personal information in general personal information you submit to us is used either to respond to requests that you make or to aid us in serving you better disclosure of personal information we do not sell your personal information or share your information with other companies or organizations without your consent the content of any communications you send to us is nonconfidential and we are under no obligation to refrain from reproducing publishing or otherwise using such content in any way or for any purpose we will not reproduce publish or otherwise use your personal information in connection with such content we may however reproduce or use your personal information in connection with any resume you submit to us for employment recruiting purposes we are free to use the content of any such communications excluding any resume you submit to us including any ideas inventions concepts techniques or knowhow disclosed therein for any purpose including developing manufacturing andor marketing goods or services although we currently do not have a parent company any subsidiaries joint ventures or other companies under a common control collectively “affiliates” we may in the future we may share some or all of your personal information with these affiliates in which case we will require our affiliates to honor this privacy policy if we are acquired by another company that company will possess the personal information collected by us and it will assume the rights and obligations regarding your personal information as described in this privacy policy regarding children our website is not designed for children under the age of  we will not deliberately gather personal information about visitors in this age group and do not collect any information on this website with respect to age links to other sites our provision of a link to any other website or location is for your convenience and does not signify our endorsement of such other website or location or its contents we have no control over do not review and cannot be responsible for these outside websites or their content please be aware that the terms of our privacy policy does not apply to these outside websites data security we use industrystandard methods to secure the communication of personal information from your computer to our servers in addition we use industrystandard methods of securing our databases of personal information including the use of firewalls except as provided elsewhere in this privacy policy we limit access to personal information databases to those persons in our organization who have a business need for such access you should know however that no company including cleveland biolabs can fully eliminate security risks associated with personal information contact us should you have any questions or concerns regarding this privacy policy please contact us cleveland biolabs inc  high st buffalo ny    privacy policy updates this privacy policy is subject to occasional revision and any changes will be posted on this site if you object to any such changes you must cease using our website continued use of our website following notice of any such changes shall indicate your acknowledgement of such changes and agreement to be bound by the terms and conditions of such changes this policy was last updated on june   about us history mission joint ventures alliances management team career opportunities pipeline entolimod cblb biodefense entolimod cblb oncology sa vaccine adjuvant cblb mobilan cbl discovery technology  scienceprotectan technology curaxin technology publications presentationsbusiness developmentlicensing opportunities investorspress releases stock quote and chart financials sec filings corporate governance cleveland biolabs  wikipedia cleveland biolabs from wikipedia the free encyclopedia jump to navigation search cleveland biolabs type public traded as nasdaq cbli industry pharmaceuticals founded cleveland ohio  headquarters buffalo new york usa key people yakov kogan ceo andrei gudkov chief scientific officer neil lyons chief financial officer products antiradiation and oncological products subsidiaries incuron llc panacela labs inc website wwwcbiolabscom cleveland biolabs inc nasdaq cbli is a clinicalstage biotechnology company with a focus on oncology development it specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome the company was founded in  and is headquartered in buffalo new york it has license agreements and collaborations with the cleveland clinic roswell park cancer institute the children’s cancer institute australia and the armed forces radiobiology research institute historyedit cleveland biolabs was founded in partnership with the cleveland clinic in  and moved to the buffalo niagara medical campus in  productsedit cblb entolimod formerly protectan is the companys most advanced compound it is being developed both as a radiation countermeasure and as a cancer treatment entolimod is being developed and tested in two contexts as an antiradiation pharmaceutical under the us food and drug administrations animal efficacy rule without human testing and as an oncological following the approval process for human pharmaceuticals entolimod acts through activation of tolllike receptor  to mobilize antitumor immune response and reduce radiation effects on normal tissues cbl is a novel small molecule that modulates fact facilitates chromatin transcription the interaction of cbl with the fact complex results in simultaneous nfkb suppression heat shock factor  suppression and p activation it demonstrated reproducible antitumor effects in animal models of colon breast renal pancreatic head and neck and prostate cancers melanoma nonsmall cell lung cancer glioblastoma lymphoma leukemia and neuroblastoma cbl is a quinacrine a compound with a long history of use in humans as a treatment for malaria osteoarthritis and autoimmune disorders more recently it has been shown that cbl interferes with a novel molecular target the fact facilitates chromatin transcription complex resulting in simultaneous nfkb suppression heat shock factor  suppression and p activation quinacrine has shown antitumor activity in subcutaneous human xenografts of renal cell carcinoma prostate adenocarcinoma and fibrosarcoma antitumor effects of cbl were shown in vitro in several human tumor cell lines including melanomas lung adenocarcinoma mammary gland adenocarcinoma and colon carcinoma cblb is a proprietary compound based upon a natural activator of tlrtlr heterodimeric receptor it structurally mimics naturally occurring lipopeptides of mycoplasma to activate nfkb via specific binding to trl which suppresses cell death stimulates the immune system and promotes tissue protection and regeneration in  the company assigned exclusive rights to development and marketing of cblb in china to zhejiang hisun pharmaceutical co ltd revercom is a preclinical cancer therapy consisting of a liposomepackaged proprietary small molecule named reversan reversan is a small molecule inhibitor of the multidrug transporter mrp which is associated with development of tumor resistance to chemotherapy mobilan is a nanoparticleformulated recombinant nonreplicating adenovirus developed as a universal cancer therapy xenomycins are antimicrobial and antifungal agents that target basic microbial transcription and replication by binding the dna of pathogens financialsedit the following table shows key financial figures for the company for   and  parenthesis represent negative figures financial measure    total assets    total liabilities    total equity    revenue    total operating expense    net income    subsidiariesedit cleveland biolabs has two majorityowned subsidiaries incuron llc is a russian federationbased joint venture founded in  between russian closed mutual venture fund bioprocess capital ventures and cleveland biolabs to develop product candidates cbl and cbl for oncology indications as of december  update cleveland biolabs owned  of incuron panacela labs inc is a joint venture company founded in  by cleveland biolabs and open joint stock company rusnano in conjunction with roswell park cancer institute childrens cancer institute australia and cleveland clinic foundation as of december  update cleveland biolabs owned  of panacela referencesedit  dan miner cleveland biolabs best shot buffalo business first bizjournals may   retrieved july    history about us cleveland biolabs retrieved july    david robinson cleveland biolabs’ officials look for signs of a turnaround cleveland biolabs officials bemoan declining stock price the buffalo news june   retrieved july    a b c d e f g h topics cleveland biolabs inc business day the new york times retrieved july    tracey drury cleveland biolabs inks chinese deal buffalo business first bizjournals september   retrieved july    cleveland biolabs inc google finance  october  retrieved  october   external linksedit official website incuron llc panacela labs inc v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitleclevelandbiolabsoldid categories biotechnology companies established in companies based in buffalo new yorkbiotechnology companies of the united statescompanies listed on nasdaq establishments in ohiohidden categories articles containing potentially dated statements from december all articles containing potentially dated statements navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  november  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view cleveland biolabs  wikipedia cleveland biolabs from wikipedia the free encyclopedia jump to navigation search cleveland biolabs type public traded as nasdaq cbli industry pharmaceuticals founded cleveland ohio  headquarters buffalo new york usa key people yakov kogan ceo andrei gudkov chief scientific officer neil lyons chief financial officer products antiradiation and oncological products subsidiaries incuron llc panacela labs inc website wwwcbiolabscom cleveland biolabs inc nasdaq cbli is a clinicalstage biotechnology company with a focus on oncology development it specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome the company was founded in  and is headquartered in buffalo new york it has license agreements and collaborations with the cleveland clinic roswell park cancer institute the children’s cancer institute australia and the armed forces radiobiology research institute historyedit cleveland biolabs was founded in partnership with the cleveland clinic in  and moved to the buffalo niagara medical campus in  productsedit cblb entolimod formerly protectan is the companys most advanced compound it is being developed both as a radiation countermeasure and as a cancer treatment entolimod is being developed and tested in two contexts as an antiradiation pharmaceutical under the us food and drug administrations animal efficacy rule without human testing and as an oncological following the approval process for human pharmaceuticals entolimod acts through activation of tolllike receptor  to mobilize antitumor immune response and reduce radiation effects on normal tissues cbl is a novel small molecule that modulates fact facilitates chromatin transcription the interaction of cbl with the fact complex results in simultaneous nfkb suppression heat shock factor  suppression and p activation it demonstrated reproducible antitumor effects in animal models of colon breast renal pancreatic head and neck and prostate cancers melanoma nonsmall cell lung cancer glioblastoma lymphoma leukemia and neuroblastoma cbl is a quinacrine a compound with a long history of use in humans as a treatment for malaria osteoarthritis and autoimmune disorders more recently it has been shown that cbl interferes with a novel molecular target the fact facilitates chromatin transcription complex resulting in simultaneous nfkb suppression heat shock factor  suppression and p activation quinacrine has shown antitumor activity in subcutaneous human xenografts of renal cell carcinoma prostate adenocarcinoma and fibrosarcoma antitumor effects of cbl were shown in vitro in several human tumor cell lines including melanomas lung adenocarcinoma mammary gland adenocarcinoma and colon carcinoma cblb is a proprietary compound based upon a natural activator of tlrtlr heterodimeric receptor it structurally mimics naturally occurring lipopeptides of mycoplasma to activate nfkb via specific binding to trl which suppresses cell death stimulates the immune system and promotes tissue protection and regeneration in  the company assigned exclusive rights to development and marketing of cblb in china to zhejiang hisun pharmaceutical co ltd revercom is a preclinical cancer therapy consisting of a liposomepackaged proprietary small molecule named reversan reversan is a small molecule inhibitor of the multidrug transporter mrp which is associated with development of tumor resistance to chemotherapy mobilan is a nanoparticleformulated recombinant nonreplicating adenovirus developed as a universal cancer therapy xenomycins are antimicrobial and antifungal agents that target basic microbial transcription and replication by binding the dna of pathogens financialsedit the following table shows key financial figures for the company for   and  parenthesis represent negative figures financial measure    total assets    total liabilities    total equity    revenue    total operating expense    net income    subsidiariesedit cleveland biolabs has two majorityowned subsidiaries incuron llc is a russian federationbased joint venture founded in  between russian closed mutual venture fund bioprocess capital ventures and cleveland biolabs to develop product candidates cbl and cbl for oncology indications as of december  update cleveland biolabs owned  of incuron panacela labs inc is a joint venture company founded in  by cleveland biolabs and open joint stock company rusnano in conjunction with roswell park cancer institute childrens cancer institute australia and cleveland clinic foundation as of december  update cleveland biolabs owned  of panacela referencesedit  dan miner cleveland biolabs best shot buffalo business first bizjournals may   retrieved july    history about us cleveland biolabs retrieved july    david robinson cleveland biolabs’ officials look for signs of a turnaround cleveland biolabs officials bemoan declining stock price the buffalo news june   retrieved july    a b c d e f g h topics cleveland biolabs inc business day the new york times retrieved july    tracey drury cleveland biolabs inks chinese deal buffalo business first bizjournals september   retrieved july    cleveland biolabs inc google finance  october  retrieved  october   external linksedit official website incuron llc panacela labs inc v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitleclevelandbiolabsoldid categories biotechnology companies established in companies based in buffalo new yorkbiotechnology companies of the united statescompanies listed on nasdaq establishments in ohiohidden categories articles containing potentially dated statements from december all articles containing potentially dated statements navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  november  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view cleveland biolabs  wikipedia cleveland biolabs from wikipedia the free encyclopedia jump to navigation search cleveland biolabs type public traded as nasdaq cbli industry pharmaceuticals founded cleveland ohio  headquarters buffalo new york usa key people yakov kogan ceo andrei gudkov chief scientific officer neil lyons chief financial officer products antiradiation and oncological products subsidiaries incuron llc panacela labs inc website wwwcbiolabscom cleveland biolabs inc nasdaq cbli is a clinicalstage biotechnology company with a focus on oncology development it specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome the company was founded in  and is headquartered in buffalo new york it has license agreements and collaborations with the cleveland clinic roswell park cancer institute the children’s cancer institute australia and the armed forces radiobiology research institute historyedit cleveland biolabs was founded in partnership with the cleveland clinic in  and moved to the buffalo niagara medical campus in  productsedit cblb entolimod formerly protectan is the companys most advanced compound it is being developed both as a radiation countermeasure and as a cancer treatment entolimod is being developed and tested in two contexts as an antiradiation pharmaceutical under the us food and drug administrations animal efficacy rule without human testing and as an oncological following the approval process for human pharmaceuticals entolimod acts through activation of tolllike receptor  to mobilize antitumor immune response and reduce radiation effects on normal tissues cbl is a novel small molecule that modulates fact facilitates chromatin transcription the interaction of cbl with the fact complex results in simultaneous nfkb suppression heat shock factor  suppression and p activation it demonstrated reproducible antitumor effects in animal models of colon breast renal pancreatic head and neck and prostate cancers melanoma nonsmall cell lung cancer glioblastoma lymphoma leukemia and neuroblastoma cbl is a quinacrine a compound with a long history of use in humans as a treatment for malaria osteoarthritis and autoimmune disorders more recently it has been shown that cbl interferes with a novel molecular target the fact facilitates chromatin transcription complex resulting in simultaneous nfkb suppression heat shock factor  suppression and p activation quinacrine has shown antitumor activity in subcutaneous human xenografts of renal cell carcinoma prostate adenocarcinoma and fibrosarcoma antitumor effects of cbl were shown in vitro in several human tumor cell lines including melanomas lung adenocarcinoma mammary gland adenocarcinoma and colon carcinoma cblb is a proprietary compound based upon a natural activator of tlrtlr heterodimeric receptor it structurally mimics naturally occurring lipopeptides of mycoplasma to activate nfkb via specific binding to trl which suppresses cell death stimulates the immune system and promotes tissue protection and regeneration in  the company assigned exclusive rights to development and marketing of cblb in china to zhejiang hisun pharmaceutical co ltd revercom is a preclinical cancer therapy consisting of a liposomepackaged proprietary small molecule named reversan reversan is a small molecule inhibitor of the multidrug transporter mrp which is associated with development of tumor resistance to chemotherapy mobilan is a nanoparticleformulated recombinant nonreplicating adenovirus developed as a universal cancer therapy xenomycins are antimicrobial and antifungal agents that target basic microbial transcription and replication by binding the dna of pathogens financialsedit the following table shows key financial figures for the company for   and  parenthesis represent negative figures financial measure    total assets    total liabilities    total equity    revenue    total operating expense    net income    subsidiariesedit cleveland biolabs has two majorityowned subsidiaries incuron llc is a russian federationbased joint venture founded in  between russian closed mutual venture fund bioprocess capital ventures and cleveland biolabs to develop product candidates cbl and cbl for oncology indications as of december  update cleveland biolabs owned  of incuron panacela labs inc is a joint venture company founded in  by cleveland biolabs and open joint stock company rusnano in conjunction with roswell park cancer institute childrens cancer institute australia and cleveland clinic foundation as of december  update cleveland biolabs owned  of panacela referencesedit  dan miner cleveland biolabs best shot buffalo business first bizjournals may   retrieved july    history about us cleveland biolabs retrieved july    david robinson cleveland biolabs’ officials look for signs of a turnaround cleveland biolabs officials bemoan declining stock price the buffalo news june   retrieved july    a b c d e f g h topics cleveland biolabs inc business day the new york times retrieved july    tracey drury cleveland biolabs inks chinese deal buffalo business first bizjournals september   retrieved july    cleveland biolabs inc google finance  october  retrieved  october   external linksedit official website incuron llc panacela labs inc v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitleclevelandbiolabsoldid categories biotechnology companies established in companies based in buffalo new yorkbiotechnology companies of the united statescompanies listed on nasdaq establishments in ohiohidden categories articles containing potentially dated statements from december all articles containing potentially dated statements navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  november  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view cleveland biolabs  wikipedia cleveland biolabs from wikipedia the free encyclopedia jump to navigation search cleveland biolabs type public traded as nasdaq cbli industry pharmaceuticals founded cleveland ohio  headquarters buffalo new york usa key people yakov kogan ceo andrei gudkov chief scientific officer neil lyons chief financial officer products antiradiation and oncological products subsidiaries incuron llc panacela labs inc website wwwcbiolabscom cleveland biolabs inc nasdaq cbli is a clinicalstage biotechnology company with a focus on oncology development it specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome the company was founded in  and is headquartered in buffalo new york it has license agreements and collaborations with the cleveland clinic roswell park cancer institute the children’s cancer institute australia and the armed forces radiobiology research institute historyedit cleveland biolabs was founded in partnership with the cleveland clinic in  and moved to the buffalo niagara medical campus in  productsedit cblb entolimod formerly protectan is the companys most advanced compound it is being developed both as a radiation countermeasure and as a cancer treatment entolimod is being developed and tested in two contexts as an antiradiation pharmaceutical under the us food and drug administrations animal efficacy rule without human testing and as an oncological following the approval process for human pharmaceuticals entolimod acts through activation of tolllike receptor  to mobilize antitumor immune response and reduce radiation effects on normal tissues cbl is a novel small molecule that modulates fact facilitates chromatin transcription the interaction of cbl with the fact complex results in simultaneous nfkb suppression heat shock factor  suppression and p activation it demonstrated reproducible antitumor effects in animal models of colon breast renal pancreatic head and neck and prostate cancers melanoma nonsmall cell lung cancer glioblastoma lymphoma leukemia and neuroblastoma cbl is a quinacrine a compound with a long history of use in humans as a treatment for malaria osteoarthritis and autoimmune disorders more recently it has been shown that cbl interferes with a novel molecular target the fact facilitates chromatin transcription complex resulting in simultaneous nfkb suppression heat shock factor  suppression and p activation quinacrine has shown antitumor activity in subcutaneous human xenografts of renal cell carcinoma prostate adenocarcinoma and fibrosarcoma antitumor effects of cbl were shown in vitro in several human tumor cell lines including melanomas lung adenocarcinoma mammary gland adenocarcinoma and colon carcinoma cblb is a proprietary compound based upon a natural activator of tlrtlr heterodimeric receptor it structurally mimics naturally occurring lipopeptides of mycoplasma to activate nfkb via specific binding to trl which suppresses cell death stimulates the immune system and promotes tissue protection and regeneration in  the company assigned exclusive rights to development and marketing of cblb in china to zhejiang hisun pharmaceutical co ltd revercom is a preclinical cancer therapy consisting of a liposomepackaged proprietary small molecule named reversan reversan is a small molecule inhibitor of the multidrug transporter mrp which is associated with development of tumor resistance to chemotherapy mobilan is a nanoparticleformulated recombinant nonreplicating adenovirus developed as a universal cancer therapy xenomycins are antimicrobial and antifungal agents that target basic microbial transcription and replication by binding the dna of pathogens financialsedit the following table shows key financial figures for the company for   and  parenthesis represent negative figures financial measure    total assets    total liabilities    total equity    revenue    total operating expense    net income    subsidiariesedit cleveland biolabs has two majorityowned subsidiaries incuron llc is a russian federationbased joint venture founded in  between russian closed mutual venture fund bioprocess capital ventures and cleveland biolabs to develop product candidates cbl and cbl for oncology indications as of december  update cleveland biolabs owned  of incuron panacela labs inc is a joint venture company founded in  by cleveland biolabs and open joint stock company rusnano in conjunction with roswell park cancer institute childrens cancer institute australia and cleveland clinic foundation as of december  update cleveland biolabs owned  of panacela referencesedit  dan miner cleveland biolabs best shot buffalo business first bizjournals may   retrieved july    history about us cleveland biolabs retrieved july    david robinson cleveland biolabs’ officials look for signs of a turnaround cleveland biolabs officials bemoan declining stock price the buffalo news june   retrieved july    a b c d e f g h topics cleveland biolabs inc business day the new york times retrieved july    tracey drury cleveland biolabs inks chinese deal buffalo business first bizjournals september   retrieved july    cleveland biolabs inc google finance  october  retrieved  october   external linksedit official website incuron llc panacela labs inc v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitleclevelandbiolabsoldid categories biotechnology companies established in companies based in buffalo new yorkbiotechnology companies of the united statescompanies listed on nasdaq establishments in ohiohidden categories articles containing potentially dated statements from december all articles containing potentially dated statements navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  november  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view cleveland biolabs  wikipedia cleveland biolabs from wikipedia the free encyclopedia jump to navigation search cleveland biolabs type public traded as nasdaq cbli industry pharmaceuticals founded cleveland ohio  headquarters buffalo new york usa key people yakov kogan ceo andrei gudkov chief scientific officer neil lyons chief financial officer products antiradiation and oncological products subsidiaries incuron llc panacela labs inc website wwwcbiolabscom cleveland biolabs inc nasdaq cbli is a clinicalstage biotechnology company with a focus on oncology development it specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome the company was founded in  and is headquartered in buffalo new york it has license agreements and collaborations with the cleveland clinic roswell park cancer institute the children’s cancer institute australia and the armed forces radiobiology research institute historyedit cleveland biolabs was founded in partnership with the cleveland clinic in  and moved to the buffalo niagara medical campus in  productsedit cblb entolimod formerly protectan is the companys most advanced compound it is being developed both as a radiation countermeasure and as a cancer treatment entolimod is being developed and tested in two contexts as an antiradiation pharmaceutical under the us food and drug administrations animal efficacy rule without human testing and as an oncological following the approval process for human pharmaceuticals entolimod acts through activation of tolllike receptor  to mobilize antitumor immune response and reduce radiation effects on normal tissues cbl is a novel small molecule that modulates fact facilitates chromatin transcription the interaction of cbl with the fact complex results in simultaneous nfkb suppression heat shock factor  suppression and p activation it demonstrated reproducible antitumor effects in animal models of colon breast renal pancreatic head and neck and prostate cancers melanoma nonsmall cell lung cancer glioblastoma lymphoma leukemia and neuroblastoma cbl is a quinacrine a compound with a long history of use in humans as a treatment for malaria osteoarthritis and autoimmune disorders more recently it has been shown that cbl interferes with a novel molecular target the fact facilitates chromatin transcription complex resulting in simultaneous nfkb suppression heat shock factor  suppression and p activation quinacrine has shown antitumor activity in subcutaneous human xenografts of renal cell carcinoma prostate adenocarcinoma and fibrosarcoma antitumor effects of cbl were shown in vitro in several human tumor cell lines including melanomas lung adenocarcinoma mammary gland adenocarcinoma and colon carcinoma cblb is a proprietary compound based upon a natural activator of tlrtlr heterodimeric receptor it structurally mimics naturally occurring lipopeptides of mycoplasma to activate nfkb via specific binding to trl which suppresses cell death stimulates the immune system and promotes tissue protection and regeneration in  the company assigned exclusive rights to development and marketing of cblb in china to zhejiang hisun pharmaceutical co ltd revercom is a preclinical cancer therapy consisting of a liposomepackaged proprietary small molecule named reversan reversan is a small molecule inhibitor of the multidrug transporter mrp which is associated with development of tumor resistance to chemotherapy mobilan is a nanoparticleformulated recombinant nonreplicating adenovirus developed as a universal cancer therapy xenomycins are antimicrobial and antifungal agents that target basic microbial transcription and replication by binding the dna of pathogens financialsedit the following table shows key financial figures for the company for   and  parenthesis represent negative figures financial measure    total assets    total liabilities    total equity    revenue    total operating expense    net income    subsidiariesedit cleveland biolabs has two majorityowned subsidiaries incuron llc is a russian federationbased joint venture founded in  between russian closed mutual venture fund bioprocess capital ventures and cleveland biolabs to develop product candidates cbl and cbl for oncology indications as of december  update cleveland biolabs owned  of incuron panacela labs inc is a joint venture company founded in  by cleveland biolabs and open joint stock company rusnano in conjunction with roswell park cancer institute childrens cancer institute australia and cleveland clinic foundation as of december  update cleveland biolabs owned  of panacela referencesedit  dan miner cleveland biolabs best shot buffalo business first bizjournals may   retrieved july    history about us cleveland biolabs retrieved july    david robinson cleveland biolabs’ officials look for signs of a turnaround cleveland biolabs officials bemoan declining stock price the buffalo news june   retrieved july    a b c d e f g h topics cleveland biolabs inc business day the new york times retrieved july    tracey drury cleveland biolabs inks chinese deal buffalo business first bizjournals september   retrieved july    cleveland biolabs inc google finance  october  retrieved  october   external linksedit official website incuron llc panacela labs inc v t e pharmaceutical companies of the united states current abbott laboratories acorda therapeutics aderis pharmaceuticals advaxis alcon alexion pharmaceuticals alkermes allergan amgen avax technologies baxter international biocryst pharmaceuticals biogen bioverativ biovest biovista bristolmyers squibb century pharmaceuticals ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cytosport cytrx danco laboratories eli lilly and company elorac endo pharmaceuticals par pharmaceutical galena biopharma genvec genentech gilead sciences institute for oneworld health intercept pharmaceuticals johnson  johnson ethicon janssen biotech mcneil consumer healthcare orthomcneil pharmaceutical kinetic concepts mallinckrodt mckesson corporation melinta therapeutics formerly ribx pharmaceuticals melior discovery mentholatum merck  co mylan myriad genetics northwest biotherapeutics norwich pharma services novabay pharmaceuticals ovation pharmaceuticals perrigo pfizer hospira searle pharmaceutical product development prasco laboratories procter  gamble proteon therapeutics purdue pharma quark pharmaceuticals regeneron repros therapeutics sarepta therapeutics savage laboratories sheffield pharmaceuticals spectrum pharmaceuticals tec laboratories teva pharmaceutical industries actavis tapi tiens biotech group titan pharmaceuticals trevena inc upshersmith laboratories valeant pharmaceuticals bausch  lomb ventria bioscience vertex pharmaceuticals west pharmaceutical services former alza amylin pharmaceuticals ariad pharmaceuticals biolex bradley pharmaceuticals cancervax cephalon cotherix covance covidien cubist pharmaceuticals cutter laboratories dnaprint genomics epix pharmaceuticals forest laboratories genta imclone systems ista pharmaceuticals king pharmaceuticals kv pharmaceutical leiner health products martek biosciences corporation s e massengill company miles laboratories naurex nereus pharmaceuticals nuvelo organon international ortho pharmaceutical osi pharmaceuticals parkedavis qualitest scheringplough smith kline  french sterling drug tanox tap pharmaceutical products trubion upjohn verus pharmaceuticals vion pharmaceuticals inc viropharma wyeth zonite products corporation list of pharmaceutical companies retrieved from httpsenwikipediaorgwindexphptitleclevelandbiolabsoldid categories biotechnology companies established in companies based in buffalo new yorkbiotechnology companies of the united statescompanies listed on nasdaq establishments in ohiohidden categories articles containing potentially dated statements from december all articles containing potentially dated statements navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  november  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view cleveland biolabs inc  product pipeline review   trends statistics segment and forecasts market size share analysis  market research store     gmt office hours  uscan toll free  us office no home categories become publisher news about us contact us select category consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media semiconductor chemical and materials metallurgical market research search home  life sciences  pharmaceuticals cleveland biolabs inc  product pipeline review   published nov  format pdf  global markets direct  number of pages   code mrs   report details table of content inquiry for buying request sample cleveland biolabs inc  product pipeline review   summary global markets direct’s ‘cleveland biolabs inc  product pipeline review  ’ provides an overview of the cleveland biolabs inc’s pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of cleveland biolabs inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of cleveland biolabs inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of cleveland biolabs inc’s human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the cleveland biolabs inc’s pipeline products reasons to buy  evaluate cleveland biolabs inc’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of cleveland biolabs inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the cleveland biolabs inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of cleveland biolabs inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of cleveland biolabs inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of cleveland biolabs inc and identify potential opportunities in those areas  avoid intellectual property rights related issues table of contents table of contents  list of tables  list of figures  cleveland biolabs inc snapshot  cleveland biolabs inc overview  key information  key facts  cleveland biolabs inc  research and development overview  key therapeutic areas  cleveland biolabs inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  cleveland biolabs inc  pipeline products glance  cleveland biolabs inc  late stage pipeline products  phase iii productscombination treatment modalities  cleveland biolabs inc  clinical stage pipeline products  phase i productscombination treatment modalities  cleveland biolabs inc  early stage pipeline products  preclinical productscombination treatment modalities  cleveland biolabs inc  drug profiles  entolimod  product description  mechanism of action  rd progress  cblb  product description  mechanism of action  rd progress  cblb  product description  mechanism of action  rd progress  m  product description  mechanism of action  rd progress  cleveland biolabs inc  pipeline analysis  cleveland biolabs inc  pipeline products by target  cleveland biolabs inc  pipeline products by route of administration  cleveland biolabs inc  pipeline products by molecule type  cleveland biolabs inc  pipeline products by mechanism of action  cleveland biolabs inc  recent pipeline updates  cleveland biolabs inc  dormant projects  cleveland biolabs inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables cleveland biolabs inc key information  cleveland biolabs inc key facts  cleveland biolabs inc  pipeline by indication   cleveland biolabs inc  pipeline by stage of development   cleveland biolabs inc  monotherapy products in pipeline   cleveland biolabs inc  phase iii   cleveland biolabs inc  phase i   cleveland biolabs inc  preclinical   cleveland biolabs inc  pipeline by target   cleveland biolabs inc  pipeline by route of administration   cleveland biolabs inc  pipeline by molecule type   cleveland biolabs inc  pipeline products by mechanism of action   cleveland biolabs inc  recent pipeline updates   cleveland biolabs inc  dormant developmental projects  list of figures cleveland biolabs inc  pipeline by top  indication   cleveland biolabs inc  pipeline by stage of development   cleveland biolabs inc  monotherapy products in pipeline   cleveland biolabs inc  pipeline by top  target   cleveland biolabs inc  pipeline by top  route of administration   cleveland biolabs inc  pipeline by top  molecule type   cleveland biolabs inc  pipeline products by top  mechanism of action   inquiry for buying please fill your details below to inquire about this report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit request sample please fill your details below to receive sample report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit related reports global oncology market to   robust growth driven by rising prevalence and increased uptake of immune checkpoint inhibitors jun  gbi research  pages    code  mrs   global oncology market to   robust growth driven by rising prevalence and increased uptake of immune checkpoint inhibitors summary in  there were  million people living with any type of cancer within five years of diagnosis these are generally incurable once they progress to the stage where they are unresectable chemotherapy compounds are a mainstay treatment for cancers of all types at various disease stages in a typical course of therapy for cancer multiple chemothera read more interleukin  receptor subunit alpha cdw or cd or ilr  pipeline review h  jul  global markets direct  pages    code  mrs   interleukin  receptor subunit alpha cdw or cd or ilr  pipeline review h  summary interleukin  receptor subunit alpha cdw or cd or ilr  interleukin receptor is a protein found on the surface of cells it is a receptor for interleukin it acts as a receptor for thymic stromal lymphopoietin tslp it plays an important role in tcell acute lymphoblastic leukemia multiple sclerosis rheumatoid arthritis and juvenile idiopathic arthritis interleukin  recep read more  kda glucose regulated protein endoplasmic reticulum lumenal ca binding protein grp or heat shock  kda protein  or immunoglobulin heavy chain binding protein or hspa  pipeline review h  jul  global markets direct  pages    code  mrs    kda glucose regulated protein endoplasmic reticulum lumenal ca binding protein grp or heat shock  kda protein  or immunoglobulin heavy chain binding protein or hspa  pipeline review h  summary  kda glucose regulated protein endoplasmic reticulum lumenal ca binding protein grp or heat shock  kda protein  or immunoglobulin heavy chain binding protein or hspa pipeline target constitutes close to  molecules out of which approximately  molecules are devel read more survival motor neuron protein component of gems  or gemin  or smn or smn  pipeline review h  jul  global markets direct  pages    code  mrs   survival motor neuron protein component of gems  or gemin  or smn or smn  pipeline review h  summary according to the recently published report survival motor neuron protein  pipeline review h  survival motor neuron protein component of gems  or gemin  or smn or smn pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies and remaining by the universitiesinstitutes survival motor neuron protein  read more rho associated protein kinase  renal carcinoma antigen ny ren  or rho associated coiled coil containing protein kinase  or p rock  or rock or ec   pipeline review h  jul  global markets direct  pages    code  mrs   rho associated protein kinase  renal carcinoma antigen ny ren  or rho associated coiled coil containing protein kinase  or p rock  or rock or ec   pipeline review h  summary rho associated protein kinase  renal carcinoma antigen ny ren  or rho associated coiled coil containing protein kinase  or p rock  or rock or ec   rhoassociated protein kinase  rock is a protein serinethreonine kinase it is a key regulator of actin cytoskeleton and read more serinethreonine protein kinase a raf proto oncogene a raf or proto oncogene pks or araf or ec   pipeline review h  jul  global markets direct  pages    code  mrs   serinethreonine protein kinase a raf proto oncogene a raf or proto oncogene pks or araf or ec   pipeline review h  summary serinethreonine protein kinase a raf proto oncogene a raf or proto oncogene pks or araf or ec  pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies the latest report serinethreonine protein kinase a raf  pipeline review h  outlays comprehensive information on the serin read more map kinase interacting serinethreonine protein kinase  map kinase signal integrating kinase  or mknk or ec   pipeline review h  jul  global markets direct  pages    code  mrs   map kinase interacting serinethreonine protein kinase  map kinase signal integrating kinase  or mknk or ec   pipeline review h  summary according to the recently published report map kinase interacting serinethreonine protein kinase   pipeline review h  map kinase interacting serinethreonine protein kinase  map kinase signal integrating kinase  or mknk or ec  pipeline target constitutes close to  molecules out of which approximately  molecu read more interleukin  receptor associated kinase  renal carcinoma antigen ny ren  or irak or ec   pipeline review h  jul  global markets direct  pages    code  mrs   interleukin  receptor associated kinase  renal carcinoma antigen ny ren  or irak or ec   pipeline review h  summary interleukin  receptor associated kinase  renal carcinoma antigen ny ren  or irak or ec   interleukin receptorassociated kinase  irak is a protein kinase involved in signaling innate immune responses from tolllike receptors mutations in irak result in irak deficiency and recurrent invasive pneumococcal disease it phosphoryla read more mitogen activated protein kinase  c jun n terminal kinase  or jnk  or stress activated protein kinase jnk or stress activated protein kinase c or mapk or ec   pipeline review h  jul  global markets direct  pages    code  mrs   mitogen activated protein kinase  c jun n terminal kinase  or jnk  or stress activated protein kinase jnk or stress activated protein kinase c or mapk or ec   pipeline review h  summary mitogen activated protein kinase  c jun n terminal kinase  or jnk  or stress activated protein kinase jnk or stress activated protein kinase c or mapk or ec  pipeline target constitutes close to  molecules out of which approximately  molecules are developed by read more protein glutamine gamma glutamyltransferase  tissue transglutaminase or transglutaminase c or transglutaminase h or transglutaminase  or tgase c or tgase h or tgm or ec   pipeline review h  jul  global markets direct  pages    code  mrs   protein glutamine gamma glutamyltransferase  tissue transglutaminase or transglutaminase c or transglutaminase h or transglutaminase  or tgase c or tgase h or tgm or ec   pipeline review h  summary according to the recently published report protein glutamine gamma glutamyltransferase   pipeline review h  protein glutamine gamma glutamyltransferase  tissue transglutaminase or transglutaminase c or transglutaminase h or transglutaminase  or tgase c or tgase read more payment mode single user  usd multi user  usd corporate user  usd latest report  global nonslip epoxy glass flake paint market research report  global parking sensors market research report  global nitrogen oxide sensor market research report  global nuclear density gauge market research report  global automotive interior materials market research report view more latest news global chitosan market set for rapid growth to reach usd  billion by  zion market research has published a new report titled chitosan market for water treatment biomed development of ecommerce to reshape global mobile hotspot router market mobile hotspot is a popular feature on smart phones that provide wireless internet access on many global carotenoids market is expected to reach around usd  billion in  zion market research has published a new report titled carotenoids market by type astaxanthin be soaring demand from food  beverages industry to act as prime driving for ascorbic acid market reports zion market research ascorbic acid is extensively available in nature mostly rich in leafy vegetables and fresh fruits global energy management system ems market is set for a rapid growth and is expected to reach usd  million by  zion market research has published a new report titled energy management system market ems by so view more single user  usd view pricing find help how to order disclaimer faqs return policy sitemap our company about us terms and conditions privacy policy we accept the following payment methods     market research store  market research reports cleveland biolabs inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports cleveland biolabs inc  product pipeline review   cleveland biolabs inc  product pipeline review   wgr  december  global  pages global markets direct description table of content sample report enquiry before buy related reports cleveland biolabs inc  product pipeline review  summaryglobal markets direct’s ‘cleveland biolabs inc  product pipeline review  ’ provides an overview of the cleveland biolabs inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of cleveland biolabs inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of cleveland biolabs inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of cleveland biolabs inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the cleveland biolabs inc’s pipeline productsreasons to buy evaluate cleveland biolabs inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of cleveland biolabs inc in its therapy areas of focus identify new drug targets and therapeutic classes in the cleveland biolabs inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of cleveland biolabs inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of cleveland biolabs inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of cleveland biolabs inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures cleveland biolabs inc snapshot cleveland biolabs inc overview key information key facts cleveland biolabs inc  research and development overview key therapeutic areas cleveland biolabs inc  pipeline review pipeline products by stage of development pipeline products  monotherapy cleveland biolabs inc  pipeline products glance cleveland biolabs inc  late stage pipeline products phase iii productscombination treatment modalities cleveland biolabs inc  clinical stage pipeline products phase i productscombination treatment modalities cleveland biolabs inc  early stage pipeline products preclinical productscombination treatment modalities cleveland biolabs inc  drug profiles entolimod product description mechanism of action rd progress cblb product description mechanism of action rd progress cblb product description mechanism of action rd progress m product description mechanism of action rd progress cleveland biolabs inc  pipeline analysis cleveland biolabs inc  pipeline products by target cleveland biolabs inc  pipeline products by route of administration cleveland biolabs inc  pipeline products by molecule type cleveland biolabs inc  pipeline products by mechanism of action cleveland biolabs inc  recent pipeline updates cleveland biolabs inc  dormant projects cleveland biolabs inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablescleveland biolabs inc key information cleveland biolabs inc key facts cleveland biolabs inc  pipeline by indication  cleveland biolabs inc  pipeline by stage of development  cleveland biolabs inc  monotherapy products in pipeline  cleveland biolabs inc  phase iii  cleveland biolabs inc  phase i  cleveland biolabs inc  preclinical  cleveland biolabs inc  pipeline by target  cleveland biolabs inc  pipeline by route of administration  cleveland biolabs inc  pipeline by molecule type  cleveland biolabs inc  pipeline products by mechanism of action  cleveland biolabs inc  recent pipeline updates  cleveland biolabs inc  dormant developmental projects cleveland biolabs inc subsidiaries list of figurescleveland biolabs inc  pipeline by top  indication  cleveland biolabs inc  pipeline by stage of development  cleveland biolabs inc  monotherapy products in pipeline  cleveland biolabs inc  pipeline by top  target  cleveland biolabs inc  pipeline by top  route of administration  cleveland biolabs inc  pipeline by top  molecule type  cleveland biolabs inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send cbli key statistics  cleveland biolabs inc financial ratios  marketwatch bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close cleveland biolabs inc nasdaq cbli go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus cleveland biolabs inc after hours  quotes are delayed by  min jul    pm cbli quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description cleveland biolabs inc is a clinicalstage biotechnology company with a focus on oncology and acute radiation syndrome drug development it is engaged in the research development and commercialization of products that have the potential to treat cancer which reduces death from total body irradiat cleveland biolabs inc is a clinicalstage biotechnology company with a focus on oncology and acute radiation syndrome drug development it is engaged in the research development and commercialization of products that have the potential to treat cancer which reduces death from total body irradiation and counteract the toxic effects of radio and chemotherapies for oncology patients the company has designed two oppositelydirected general therapeutic concepts temporary and reversible suppression of apoptosis in normal cells to protect healthy tissues from stressinduced damage using compounds categorized as protectans and reactivation of apoptosis in tumor cells to eliminate cancer using compounds categorized as curaxins the company was founded by andrei v gudkov and yakov kogan on june   and is headquartered in buffalo ny valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title dr langdon l miller   president  chief medical officer dr yakov kogan   chief executive officer mr john szydlo   chief financial officer  secretary dr andrei v gudkov   chief scientific officer ms rachel levine   vice presidentinvestor relations insider actions – purchase – sale  – number of transactions  except as otherwise noted the content of this page is licensed under the creative commons attribution  license and code samples are licensed under the apache  license for details see our site policies java is a registered trademark of oracle andor its affiliates last updated february   send feedback about this page documentation feedback freebase api deprecated product feedback cancel